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95. INTRODUCTION
Water homeostasis is essential for normal brain function. In contrast to other organs, the brain 
is encased in a rigid skull. Thus, it cannot expand freely. Brain edema (net increase in brain 
water) is a life-threatening condition that calls for immediate action. Cerebral edema may 
increase intracranial pressure (ICP) and decrease cerebral perfusion, potentially leading to 
brain ischemia, herniation and death. Brain edema is associated with a plethora of medical 
conditions such as stroke, hyponatremia and meningitis; to name a few. Alas, the therapeutic 
options have not evolved significantly over the last eighty years and are still based mainly on 
surgical decompression or mannitol infusion (Bereczki et al., 2001; Jaeger et al., 2003; 
Bereczki et al., 2007). Needless to say, drilling through the scull is bound to be associated 
with bleeding and infections. The initial effect of mannitol administration is significant, but a 
rebound edema may occur because of leakage of mannitol into the brain parenchyma through 
a decaying blood-brain barrier. The current therapy does not target the molecular mechanisms 
that transport water in and out of the brain. Hence, there is an imminent need for novel 
therapeutic options. Thus, a molecular approach to the pathogenesis of brain edema was 
pursued in this thesis.  
                                       
             Fig 1. Schematic presentation of an astrocyte with aquaporin-4 water channels  
             embedded in the plasma membrane. Arrows indicate hypothetic water fluxes 
             in the brain (Amiry-Moghaddam et al., 2004a) 
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Water transport in brain: Hallmark of astrocytes
Astrocytes are highly polarized cells (Fig. 1). From the cell body, the astrocyte branches off 
with numerous processes. These processes abut onto nearby capillaries (the perivascular 
endfeet), the pia mater (the subpial endfeet) and the ependymocytes (the glia limitans interna). 
All these endfeet are in contact with the brain-blood or brain-CSF interfaces.  
Thus, the astrocyte is uniquely situated to be the key player in the regulation of water 
transport in the brain. A selective swelling of the perivascular endfeet is almost 
pathognomonic for some types of cerebral edema (Table 1). Astrocytes are endowed with a 
number  of organic osmolytes (mainly amino acids) – and inorganic osmolytes (of which  K+
is the quantitatively most important).  These can be released so as to temporarily  counteract  
edema formation (Thurston et al., 1975; Sterns et al., 1993). 
Table 1.  Classification of brain edemas
Edema Edema fluid Mechanism Clinical condition 
Cytotoxic Intracellular 
(glia) 
ATP depletion 
Reversal of Na/K 
ATPase 
Ischemia  
Toxins 
Meningitis? 
Osmotic Intracellular 
(glia) 
Osmotic  gradients Hyponatremia 
The syndrome of inappropriate antidiuretic 
hormone hypersecretion (SIADH) 
Reversal of hyperglycaemia  
Vasogenic  Extracellular Disrupted blood-brain 
barrier 
Brain tumors 
Prolonged ischemia  
Meningitis 
Hydrocephalic Extracellular Decreased resolution of 
CSF and  
brain water 
Hydrocephalus 
Meningitis? 
When addressing brain edema, it is of paramount importance to know the distinction between 
the different classes of edema, because the pathophysiological mechanisms (and potential 
treatment) are very different. Cytotoxic (cellular) edema and vasogenic edema are the two 
classic types of edema as defined and investigated by the famous neuropathologist Igor Klatzo 
(Klatzo, 1987). Recently, further insight into the edema mechanisms has recognized osmotic- 
and hydrocephalic edema as distinct entities (Milhorat, 1992). 
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Recently, the discovery that a selective water channel (Aquaporin-4) is abundantly expressed 
in astrocyte endfeet has provided new insight into the molecular basis of water transport in the 
brain and instills hope for more efficient therapy 
Emerging role of aquaporins in fluid physiology
Physiologists have long debated how large amounts of water are transported over cell 
membranes in cells or organs like erythrocytes and kidney as this transport exceeds 
severalfold what can be accounted for by simple diffusion. 
The discovery that nearly every organ in the body is endowed with specific channels 
selectively transporting water has lead to a paradigm shift in our understanding of basic fluid 
physiology (Preston and Agre, 1991; Agre et al., 2002). To date, 13 mammalian members of 
the aquaporin family have been characterized. Each has a distinct cellular and subcellular 
localization. The mammalian aquaporins fall into three functional groups. 
The first group compromises the true aquaporins, which are permeated by water only: AQP0, 
AQP1, AQP2, AQP4, AQP5 and AQP6 (Preston and Agre, 1991; Fushimi et al., 1993; Jung 
et al., 1994a; Mulders et al., 1995; Raina et al., 1995; Yasui et al., 1999b). However, AQP6 is 
a special case as its water permeability is increased at low pH and becomes permeable to urea, 
glycerol and anions if stimulated by mercury (Yasui et al., 1999a; Holm et al., 2004). 
Members of the second group, named the aquaglyceroporins, consist of AQP3, AQP7, AQP9 
and AQP10 (Ishibashi et al., 1994; Ishibashi et al., 1997; Kuriyama et al., 1997; Ishibashi et 
al., 2002). They are permeable to water, ammonia, glycerol and urea (Rojek et al., 2008).  
AQP8 is a loner in the last group, the aquaammoniaporins, and is permeable to water and 
ammonia (Saparov et al., 2007).    
The two last members AQP11 and AQP12, which were recently identified, belong to a new 
subfamily, the superaquaporins. They are still poorly characterized and little is known about 
their roles. However, AQP11 is proposed to be expressed in intracellular organelles 
(endoplasmic reticulum) in kidney tubules and in a subset of neurons and lacks water 
transport capacity (Gorelick et al., 2006). Unexpectedly, AQP11 null mice die before 
weaning, due to advanced renal failure with polycystic kidneys (Morishita et al., 2005).  
Finally, AQP12 is expressed intracellularly in pancreatic acinar cells (Itoh et al., 2005).  
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3D structural studies by X-ray crystallography studies have shown that AQP1 and other 
aquaporins are present as tetramers in the cell membrane (Walz et al., 1994). Unlike ion 
channels, the channel for water permeability does not reside at the centre of the tetramer. 
Instead, each of the four proteins of a tetramer contains a channel (Preston et al., 1993). 
The hallmark of the monomeric structure of the aquaporin family is the three amino acid 
signature NPA (Asn- Pro- Ala) (Jung et al., 1994b). One NPA motif is found in the amino 
terminal half of each monomer, and a second NPA motif in the carboxy terminal half. The 
NPA motif is well conserved among the aquaporin family members (Park and Saier, Jr., 
1996). 
The selectivity of true aquaporins to water- excluding even hydronium ions - arises from three 
mechanisms. First, the channel narrows to a diameter of 3 Å which limits the size of 
molecules that can pass through it. A water molecule has a diameter of 2.8 Å (Murata et al., 
2000). Secondly, two dipoles at the NPA motifs interact with each individual water molecule 
and prevent them from hydrogen bonding to adjacent water molecules (de Groot and 
Grubmuller, 2001). Finally, a positive charged residue (Arg-195) in the pore prevents cation 
flux (e.g. hydronium ions) (de Groot et al., 2001).
As for diffusion in general, the transport of water through aquaporins is dependent on an 
osmotic gradient across the membrane. Thus, aquaporins permit bi-directional water transport. 
Since the water transport depends on osmotic forces, there is no direct energy consumption 
involved in aquaporin mediated water flux.  
Aquaporin-4 – the major aquaporin in brain
Aquaporin-4 (AQP4) is a water-selective channel originally characterized in 1994 and shown 
to be strongly expressed in brain (Jung et al., 1994a).  
AQP4 is expressed primarily in astrocytes and is polarized in the perivascular endfeet around 
blood vessels and endfeet in contact with the pial surface, both brain-liquid interfaces 
(Nielsen et al., 1997). AQP4 is also expressed in the astrocyte membranes in the neuropil, 
albeit at a far lower concentration. 
The AQP4 mRNA gives rise to two main isoforms: M1 (323 aa) and M23 (301 aa) (Jung et 
al., 1994a). The M23 isoform is by far the more abundant  and is also more widely expressed 
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than M1 (Nielsen et al., 1997). Further, freeze-fracture analyses have revealed that M23 
tetramers form orthogonal arrays of particles (OAPs), i.e., arrays of several tetramers 
clustered together (Verbavatz et al., 1997; Rash et al., 1998). The physiological implication of 
this peculiar arrangement of AQP4 is still elusive. M1 does not form OAPs alone.  
Regulation of AQP4 expression
The short-term regulation of AQP4 expression has been shown to be dependent on 
endocytotic pathways and the action of several kinases (Verbavatz et al., 1997; Madrid et al., 
2001; Gunnarson et al., 2008; Moeller et al., 2009). The dynamics of the AQP4 trafficking 
and recycling along the endocytic pathway in vivo in brain is currently unknown. In Xenopus 
laevis oocytes, activation of the vasopressin-receptor (V1aR) and subsequent PKC dependent 
phosphorylation of serine 180 in loop D mediates increased internalization of AQP4 (Moeller 
et al., 2009). Interestingly, phosphorylation of serine 276 by casein kinase II has been shown 
to enhance AQP4 lysosomal targeting and degradation in epithelial MDCK cells (Madrid et 
al., 2001). In general, the regulation of AQP4 expression bears directly on the potential of 
AQP4 as a therapeutic target.   
Glutamate excitotoxicity is proposed to play a pivotal role in the formation of postischemic 
cytotoxic edema. A proposed mechanism is that glutamate activates metabotropic glutamate 
receptors, causing  Ca2+ release from intracellular stores, with a subsequent increase in [Ca2+]i. 
Calcium release activates calcium/ calmodulin-dependent protein kinase II (CaMKII) with 
subsequent phosporylation of serine 111 on AQP4 (Gunnarson et al., 2008). Glutamate did 
not increase water permeability in astrocytes lacking AQP4.  Intriguingly, the effect of 
glutamate on water permeability in AQP4-expressing astrocytes also involves the NO 
signalling pathway, as the increase is abolished by applying inhibitors to NO synthases. 
AQP4 expression was not changed after glutamate exposure, and this begs the question if the 
decrease in water permeability is due to alterations in the structure of OAPs or single channel 
conformation (e.g. gating) (Gunnarson et al., 2008). However, the physiological relevance of 
AQP4 regulation is still obscure. 
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Fig.2 A) A low magnification image from the contact region between an astrocyte endfoot (white    
asterix) and the edge of a capillary (black asterix). Boxed area encloses astrocyte endfoot membrane. 
B) High-magnification view of astrocyte endfoot plasma membrane, showing numerous OAPs of AQP4 
Modified from Frydenlund et al. PNAS 2006. 
Aquaporin-4 multimerization
Several lines of evidence suggest that the M23 isoform assembles into OAPs in cell plasma 
membranes, whereas the full-length M1 isoform alone does not. A current hypothesis that has 
gained experimental support is that M1 may modulate the size of the OAPs. Thus, M23 alone 
forms very large OAPs, whereas M23 and M1 together form much smaller OAPs.  
Recently, the molecular details for the dynamics of OAP formation have been elucidated. By 
employing the single particle tracking technique it has been shown that the M23 isoform is 
nearly stationary whereas the M1 isoform diffuses freely in the membrane (Crane et al., 
2009b). Furthermore, single-channel water transport p(f) (cm/s) was found to be much greater 
for the M23 isoform (Silberstein et al., 2004). On the contrary, a recent analysis with the 
Xenopus oocyte assay found higher relative water permeability for the M1 isoform (Fenton et 
al., 2010). 
In one study, expression of an M23 serine 111 mutant (S111E), mimicking the constitutive 
phosphorylation of this residue, produced approximately 1.5-fold greater single-channel p(f) 
and OAPs that were significantly larger than wild type M23 OAPs, suggesting that serine 111 
may be involved in OAP formation (Silberstein et al., 2004).  
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Besides, it has been shown that two N-terminal cysteines of M1 are palmitoylated and this 
suggests that palmitoylation of the N-terminal cysteines is one of the reasons for the inability 
of M1 to form square arrays alone and that the hydrophobic residues in the N-terminus of 
M23 is important in array formation (Suzuki et al., 2008). Thus, deletion of the two cysteins 
(at position 13 and 17) in the N-terminus of M1 results in OAP formation, and furthermore, 
AQP1, which does not form OAPs, was induced to form OAPs upon replacement of its N-
terminal domain with that of M23 (Crane et al., 2009a).   
   
In conclusion, it seems that the formation of OAPs is highly regulated. The water flux through 
AQP4 may potentially be manipulated by interfering with the formation and dissolution of 
OAPs.  
The polarization of AQP4 is a main focus of this thesis. The molecular basis for polarization 
of AQP4 in the perivascular endfeet has been characterized in some detail, and it has been 
resolved that AQP4 is anchored to the endfeet membranes through interaction with the 
dystrophin-associated protein complex (DAPC) (Fig 3.). 
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    Fig. 3. Diagram showing the presumed molecular basis for the enrichment of AQP4 
    in the perivascular membrane (Amiry-Moghaddam et al., 2004a). 
DAPC- the molecular basis for astrocyte polarization
The dystrophin-associated protein complex (DAPC) is a huge assembly of proteins expressed 
in several organs. The dystrophin gene is the biggest in the genome and localized on the X-
chromosome. Mutations in the dystrophin gene lead to muscular dystrophies in male 
offspring. In Duchenne muscular dystrophy, there is a complete loss of dystrophin, but in 
Becker muscular dystrophy some aberrant dystrophin is usually transcribed and the phenotype 
is less severe (Hoffman et al., 1988). Several isoforms of  dystrophin exist: The full length 
isoform (Dp427) is expressed mainly in skeletal muscle, whereas Dp71 is the main dystrophin 
isoform in astrocytes (Lederfein et al., 1992). 
Several lines of evidence suggest that APQ4 is part of the DAPC in brain. Mdx mice is a 
strain arising from a spontaneous mutation in the dystrophin gene in inbred C57BL/10 mice 
(Bulfield et al., 1984). Thus, the mice lack dystrophin expression and interestingly also have 
perturbed expression of AQP4 (Liu et al., 1999). The perivascular expression of AQP4 in 
these mice is strongly reduced, while the total brain AQP4 levels assessed by immunoblots 
are unchanged.  
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-Syntrophin is a scaffolding adaptor protein primarily expressed in skeletal muscle and 
astrocytes and an important contributor to the formation of the DAPC  in brain (Adams et al., 
1993). The C-terminus of -syntrophin binds dystrophin, while the PDZ domain recruits other 
proteins to the dystrophin complex. The PDZ domains are found in many proteins and recruit 
molecules with a specific C-terminal sequence (SXV) into complexes (e.g. the  synaptic PSD-
95 complex) (Kornau et al., 1995).  
APQ4 has a SSV sequence and interestingly, in a transgenic mice strain (Delta-PDZ) where 
-syntrophin lacks the PDZ domain, AQP4 was absent from the sarcolemma (Adams et al., 
2001). Prompted by this finding, Neely and co-workers showed that the polarization of AQP4 
in the perivascular membrane was dependent on the expression of -syntrophin (Neely et al., 
2001). Thus, -syntrophin null mice exhibited an almost complete loss of the perivascular 
pool of AQP4, but also in this case, the total amount of brain AQP4 was unchanged (Neely et 
al., 2001). However, pools of AQP4 independent of the DAPC and -syntrophin exist. Such 
pools are found in  astrocyte membranes in the neuropil of the granule cell layer  in the 
cerebellum, in  subpial membranes in the neocortex, and in the basolateral membranes of 
ependymal cells (Amiry-Moghaddam et al., 2004b; Nicchia et al., 2008). The molecular basis 
for polarization of AQP4 in these membranes is still enigmatic.  
The insight in the molecular mechanisms underlying the polarized expression  of AQP4 has 
provided a platform for  the construction of transgenic mice and for the establishment of 
relevant models to assess APQ4 function.  
The construction of AQP4 null mice or mice that have an altered expression pattern (-
syntrophin KO) has given valuable knowledge about the physiological and pathophysiological 
importance of AQP4 and has provided strong evidence that AQP4 is in fact an important 
player in several intracerebral pathologies.  
The AQP4 null mouse model can be utilized to assess the global effect of knocking out all 
AQP4 pools in the brain (Ma et al., 1997).  The -syntrophin KO model, in contrast, is a 
selective and unique tool for assessing the functional importance of the AQP4 pool in the 
perivascular membrane (Adams et al., 2000). 
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Loss of astrocyte polarization in brain pathophysiology 
Recently, evidence has accumulated to suggest that several disorders in the CNS are 
associated with a loss of glia polarization. An important goal is to unravel the 
pathophysiological impact of the concomitant redistribution of AQP4. 
 Role of AQP4 in neuronal excitability and epilepsy
The extracellular space (ECS) shrinks significantly upon neuronal depolarization (Dietzel et 
al., 1982). Hence, this could reflect water transport through the AQP4 pool that resides in 
perisynaptic astrocytic processes. Interestingly, the ECS is shown to increase in neuropil 
distant to the active synapses (Niermann et al., 2001). This provides us with a model where 
water uptake in one astrocytic membrane compartment is followed by a net efflux of water 
(reflected by an increase in ECS) in another membrane compartment. Mice lacking AQP4 
have a slightly increased ECS (Binder et al., 2004b). Moreover, by recording cortical surface 
photobleaching of fluorescently labeled dextrans in vivo, it has been shown that extracellular 
diffusion of dextrans is faster in AQP4 KO animals than in WT controls (Binder et al., 
2004b). 
The inwardly rectifying potassium channel Kir4.1 is  proposed to act in concert with AQP4 in 
the dynamic regulation of the ECS and in the setting of baseline ECS volume (Nagelhus et al., 
1999). Further, this channel is responsible for a very negative membrane potential in 
astrocytes and is a key regulator of K+ homeostasis, at least in glial Müller cells in retina. 
Here extracellular K+ is taken up via Kir4.1 distally and siphoned through the pool of Kir4.1 
in the subvitreal endfeet into the vitreous body, that acts as a sink (Karwoski et al., 1989; 
Kofuji et al., 2000). In conclusion, AQP4 might be involved in the dynamic regulation of the 
ECS. However, much more work is required to unravel the precise mechanisms underlying 
ECS volume control and the proposed interplay between AQP4 and Kir4.1 (Ostby et al., 
2009).  
Epilepsy is a major cause of morbidity worldwide. The neurobiological substrate for epileptic 
seizures is increased excitability in neurons, focally or globally.  
The first direct evidence for a role of the perivascular AQP4 in epileptic seizures and the 
coupling between water flux and K+ clearance was provided by Amiry-Moghaddam and co-
workers (Amiry-Moghaddam et al., 2003b). Deletion of the perivascular pool of AQP4 by  
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-syntrophin KO was found to delay clearance of K+ following high frequency neuronal 
activation in acute hippocampal slices. Furthermore, mice lacking perivascular AQP4 
exhibited more severe seizures than wild type animals when exposed to hyperthermia. It was 
proposed that the perivascular pool of AQP4 is coupled in series with the perisynaptic AQP4 
pool and that both pools must be in place to ensure adequate K+ clearance. Interestingly, one 
study found increased threshold for induction of seizures in APQ4 KO mice (Binder et al., 
2004a). One possibility is that the increased seizure threshold reflects the increased ECS 
volume in AQP4 KO mice. Obviously, an increased ECS would serve to blunt the 
extracellular K+ increase caused by neuronal activation.  The role of AQP4 in epileptiform 
activity is still far from resolved, calling for further studies.   
The experimental data suggesting a role of perivascular AQP4 in potassium and water 
homeostasis after neuronal depolarization, have partly been corroborated by clinical findings.  
Thus, in a severe form of epilepsy, the mesial temporal lobe epilepsy (MTLE), 
there is atrophy of neurons and astroglial changes in the hippocampus (Thom et al., 2009). 
Interestingly, the capacity for uptake of potassium after neuronal depolarization is decreased 
(Bordey and Spencer, 2004). Further, it was recently shown that the main dystrophin isoform 
in astrocytes (Dp71) is lost from the perivascular membrane, pointing to lost polarization of 
the glial endfeet. AQP4 is anchored to the DAPC and in MTLE the polarization of AQP4 is 
lost from the perivascular endfeet, whereas the total level of AQP4 was increased (Eid et al., 
2005). This begs the question if the lost polarization of AQP4 is contributing to the 
pathophysiology and the reduced clearance of potassium.  
However, a causal relationship remains to be established as  the resected brain material 
studied was acquired from patients with fully developed epilepsy.    
Brain tumor
Glioblastoma is a type of cancer that is feared due to its ability to diffusely invade the 
neighboring brain tissue and its proneness to induce brain edema and hernation. Alas, the 
treatment options are limited. Radical surgery with severe side effects may prolong the 
survival for some months, but the patient will inevitably succumb in the end.  
In glioblastomas there is a substantial loss of astrocyte polarization. Hence, AQP4  
and -syntrophin are redistributed from the perivascular membrane to the entire surface of the 
astrocyte (Warth et al., 2004). The molecular substrate for the loss of polarization in 
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glioblastomas is not known but inflammation and proteolysis of the perivascular basal lamina 
(responsible for anchoring the dystrophin complex) might play a role.  
Several lines of evidence suggest that the integrity of the DAPC is contingent on interaction 
between dystroglycans in the astrocyte and extracellular matrix (ECM) molecules as agrin in 
the basal lamina (Ibraghimov-Beskrovnaya et al., 1992). Hence, the activity of matrix 
metalloproteinases (MMPs) is significantly increased in gliomas, and MMPs have several 
ECM components (such as agrin and laminin) as substrates (Galloway et al., 1983; Rao et al., 
1993).  
The lost polarization is likely to have pathophysiological relevance. AQP4 helps  increase 
taxis of cells by increasing their ability to undergo dynamic volume changes and hence their 
ability to navigate in the tortuous extracellular space (Auguste et al., 2007). Indeed, inhibition 
of PKC in gliomas reduced AQP4 phosporylation and significantly enhanced tumor invasion 
(McCoy et al., 2010). 
Cerebral stroke
Stroke is the third leading cause of death and a major cause of disability in the industrialized 
world (Lloyd-Jones et al., 2009). The incidence is expected to sky-rocket as the population 
ages. 
Again, therapeutic options are limited. Promising candidate targets from animal experiments 
have disappointed in human clinical trials. Tissue plasminogen activator (tPA) has been 
shown to be beneficial, however, the risk of bleeding is significantly increased so the time-
window has been limited to patients with a symptom debut less than 4 ½ h prior to admission 
(Schellinger et al., 2004). Thus, only 2-3 percent of stroke patients receive tPA and the 
clinical usefulness is therefore still limited.  
Particularly challenging are thrombotic strokes in the inlet of the middle cerebral artery.  
In early stroke pathophysiology, the brain area where blood flow is either absent or measures 
less than 10 ml/100 g brain tissue/min is rapidly and irreversibly damaged in less than 6 
minutes, forming an ischemic core. This infarcted tissue is surrounded by a border zone of 
hypoxic, but living tissue with blood flow greater than 20 ml/100 g brain tissue/min. Cells in 
the border zone undergo cytotoxic edema and other changes that are potentially reversible if 
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perfusion is restored within the first few hours after injury. If not, the cells with cytotoxic 
edema will inevitably die and extend the area with cell death deeper into the parenchyma than 
the original core (Simard et al., 2007). Hence, the cells in the border zone are the main 
therapeutic target in the prevention of ischemic stroke and injury.  
With manifest infarction there is also a gradual increase in vasogenic edema, but this may 
take hours to days. The activation of matrix metalloproteinases is a key event  in the 
inflammation associated with stroke and has been shown to contribute to the formation of 
vasogenic edema, by proteolytic degradation of the basal lamia separating the  capillary from 
the endfoot (Rosenberg et al., 1996).  
Recent analyses revealed that the integrins are lost and the astrocyte endfoot detached from 
the basal lamina soon after onset of ischemia (Tagaya et al., 2001; Kwon et al., 2009). This 
may affect astrocyte polarization and  contribute to the pathophysiological events. 
Emerging role of AQP4 in meningitis and brain edema
Bacterial meningitis is an inflammation of the meninges affecting the pia, arachnoid and 
subarachnoid space that occurs in response to bacteria and bacterial products. Meningitis 
continues to be an important cause of mortality and morbidity in neonates and children 
worldwide (Chang et al., 2004). 
AQP4 and bacterial meningitis
Bacterial meningitis is still after three generations of the availability of efficient antibiotics a 
major cause of death and disability in children and youngsters worldwide (Lin and Safdieh, 
2010). The majority of cases of acute bacterial meningitis are caused by the mucosal 
opportunistic pathogens Streptococcus pneumoniae (the pneumococcus, Pc), Neisseria 
meningitidis (the meningococcus, Mc) and Haemophilus influenzae (Davidsen et al., 2007). 
The vaccine against H. influenzae type B (Hib) given to children as part of their routine 
immunizations has dramatically reduced the occurrence of serious H. influenzae disease. 
Currently, vaccines against major serogroups of Pc and Mc are available. 
However, a vaccine against Mc serogroup B is not yet available (Tonjum, 2005; Davidsen and 
Tonjum, 2006).Today, N. meningitidis and S. pneumoniae are the leading causes of bacterial 
meningitis. 
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Even though the seriousness of S. pneumoniae and N. meningitidis infection is well known, 
the exact interplay between microbe and host is still elusive (Davidsen and Tonjum, 2006; 
Weber and Tuomanen, 2007; Orihuela et al., 2009). This has impeded the development of 
new therapeutic options based on an understanding of the molecular pathogenesis (Davidsen 
et al., 2007). Undoubtedly, antibiotics can be lifesaving, however, the inflammatory cascade 
persists after the start of treatment due to release of antigenic components from decaying 
bacteria, potentially leading to brain edema. This may ultimately cause increased intracranial 
pressure and in fatal cases herniation and death of the patient. Cerebral herniation occurs in 
about 5% of patients with acute bacterial meningitis, accounting for about 30% of the 
mortality (Joffe, 2007). Corticosteroids are recommended as an adjuvant to antibiotics in the 
treatment of pneumococcal meningitis to reduce the host inflammatory response and secure 
the integrity of the blood-brain barrier (Koedel et al., 2010). Recent animal experiments have 
shown increased apoptosis in the hippocampal formation that could question the usefulness of 
corticosteroids in the clinic (Leib et al., 2003). 
                                                   
                     Fig. 4. EM image of piliated N. meningitidis H44/76 wildtype strain (Tønjum, 2005)
N. meningitidis, a Gram-negative diploccous, is a strict human pathogen and is also 
commonly a constitutive part of the normal upper airway flora (Tonjum, 2005; Davidsen et 
al., 2007; Weber and Tuomanen, 2007). The pathogenesis of N. meningitidis is contingent on 
several virulence factors (Nassif, 2000; Tonjum, 2005). The key virulence factor is the 
production of a polysaccharide capsule shown to mediate protection against phagocytic 
killing, opsonization and complement-mediated killing (Goldschneider et al., 1969a; 
Goldschneider et al., 1969b). Of prime importance for virulence are the long, polymeric 
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structures emanating from the bacterial surface, as they are a prerequisite for adherence and 
infection. The bacteria also express an IgA1 protease, increasing the ability to thrive on mucus 
membranes. Thus, N. meningitidis is partly protected from the immune system. 
Occasionally, N. meningitidis may transverse the epithelium by transcytosis and enter the 
bloodstream (Stephens et al., 2007). Bacteremia may develop into full blown sepsis or the 
bacteria may adhere to brain capillaries and then subsequently pass through the blood-brain 
barrier, ultimately causing meningitis. However, the mechanism of meningococcal invasion 
and passage through the mucosa and blood-brain barrier is only partially known.  Filamentous 
appendages (type IV pili) (Fig. 3.) are a prerequisite for adherence to the mucosal and 
capillary surfaces (Pujol et al., 1999). Interestingly, bacteria isolated from blood or the 
cerebrospinal fluid (CSF) of patients with sepsis and meningitis are heavily encapsulated, 
suggesting that capsule formation is a key step in the transition from the nasopharyngeal state 
to invasive CNS disease (Nassif, 2000). 
Lipooligosaccharide (LOS) in the outer membrane is a potent activator of TLR4 on meningeal 
macrophages, astrocytes and microglia.  The subsequent release of cytokines (i.e. TNF-/ IL-
1) attracts circulating granulocytes and monocytes into the CSF. As they lyse, granulocytes 
and monocytes release powerful lysosomal enzymes and free radicals, which may ultimately 
lead to disruption of the blood-brain barrier.  
S. pneumoniae is an alpha-hemolytic, Gram-positive bacterium which has several disease 
manifestations; the most important ones being pneumonia, otitis media and meningitis. 
The capsule is the major virulence factor of S. pneumoniae, as the non-encapsulated strains 
are only barely pathogenic (Avery and Dubos, 1931; Watson and Musher, 1990). Other key 
virulence factors are cell wall components (peptidoglycan) and pneumolysin.  
As S. pneumoniae is a naturally virulent pathogen in mice, this pathogen has been studied in 
several mouse models for experimental bacterial meningitis (Chiavolini et al., 2004; Orihuela 
et al., 2009).  
Currently, there seems to be uncertainty as to the mechanisms and prevalence of brain edema 
in meningococcal meningitis. This can partly be attributed to the diverse disease 
manifestations of meningococcal meningitis, such as disseminated intravascular coagulation, 
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thrombosis, vasculitis, and parenchymal inflammation with possible abscess formation 
(Bauserman and Naul, 2003; Stephens et al., 2007). 
After the inflammation in meningitis has subsided and the bacteria have been eradicated, a 
thick fibrinopurulent exudate in the subarachnoid space may organize into fibrous tissue that 
blocks the exits of the fourth ventricle and impairs CSF circulation around the cerebral 
convexities (Koedel et al., 2010). This may lead to manifest postinfectious hydrocephalus. 
Other frequent sequela are deafness and epilepsy (Pumain and Heinemann, 1985; Edmond et 
al., 2010). 
  
In a recent study, S. pneumoniae was infused into the basal cisterna of CD1 mice 
(Papadopoulos and Verkman, 2005). The mice developed brain edema, with a very high 
mortality.  However, CD1 outbred mice lacking AQP4 had a tremendous reduction in edema 
formation and mortality. Based on the facts that perivascular endfeet were swollen, tight 
junctions were intact, and diffusion was reduced in the intercellular space, the authors 
concluded that the primary edema was likely to be cytotoxic. AQP4 was reported to be up-
regulated 7-fold in the neocortex of wild type mice, following S. pneumoniae infusion. In 
another study, intracerebrospinal administration of IL-1 in otherwise  
non-manipulated mice led to a significant upregulation of AQP4 (Ito et al., 2006). 
Interestingly, inhibition of the nuclear factor-B pathway abolished the induction of AQP4. 
Although intriguing findings, the exact mechanisms for this extreme increase in AQP4 are at 
present obscure. However, the potential for targeting AQP4 in the treatment of pneumococcal 
meningitis is obvious (Papadopoulos and Verkman, 2008).    
AQP4 could potentially be a key player in brain edema formation in meningococcal 
meningitis as well. However, the cell wall components of S. pneumoniae (peptidoglycan and 
teichoic acid) and the outer membrane lipopolysaccharide of  N. meningitidis (LOS) partly 
activate different cascade systems, in addition to the common effect through IL-1. Thus, the 
potential role of AQP4 in brain edema formation in meningococcal meningitis is a priori
difficult to predict.   
Despite this serious challenge, animal models of meningococcal meningitis are few and a 
valid model has yet to be established in mice. In order to benefit from the ever-increasing 
number of transgenic mice strains available, including a transferrin-overexpressing iron-
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binding strain it is of paramount importance to establish a valid mouse model for 
meningococcal meningitis (Zarantonelli et al., 2007). 
AQP4: specific role in brain edema formation and resolution 
AQP4 holds a strategic position at the brain-fluid interfaces, pointing to AQP4 as a key player 
in brain water transport. The pathophysiological importance of AQP4 has been elucidated in 
several mouse models of brain edema. 
Cytotoxic and osmotic edema 
Cytotoxic edema 
A pioneer study revealed the effect of AQP4 KOs on outcome in a model of ischemic stroke 
(Manley et al., 2000). The MCAO model is based on temporary occlusion of the middle 
cerebral artery by a nylon filament for 90 min followed by reperfusion. 24 h after ischemia 
followed by reperfusion transgenic mice lacking AQP4 showed dramatically reduced brain 
edema formation and increased survival. 
  
Moreover, -syntrophin KO mice developed less edema than WT controls after MCAO 
(Amiry-Moghaddam et al., 2003a). Serial brain sections were treated with 
triphenyltetrazolium chloride (a mitochondrial stain) to differentiate between infarcted and 
non-infarcted tissue. Interestingly, the infarction core was reduced in -syntrophin KO mice. 
Osmotic edema 
Hypotonic hyponatremia is associated with a wide range of conditions, e.g. endocrine 
disorders,  renal- and heart failure; all adversely affecting the water and electrolyte balance in 
the brain (Sonnenblick et al., 1993; Hanna and Scanlon, 1997; Adrogue and Madias, 2000; 
Moritz and Ayus, 2007). Hyponatremic edema may also be iatrogenic (too extensive use of 
diuretics or hypotonic fluids). 
The decrease in brain osmolality will inevitably set up an osmotic gradient forcing water into 
the brain. Intriguingly, the survival and outcome after acute hyponatremia produced by 
intraperitoneal water infusion were greatly improved in both AQP4 KO and -syntrophin KO 
mice (Manley et al., 2000; Amiry-Moghaddam et al., 2004b).  
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Vasogenic and hydrocephalic edema 
We now have a large quantity of experimental data from AQP4 null mice in models for  
vasogenic and hydrocephalic edema, such as cortical freeze injury, brain tumor, brain abscess 
and hydrocephalus (Papadopoulos et al., 2004; Bloch et al., 2005; Bloch et al., 2006). 
Vasogenic edema 
In one study, Staphylococcus aureus was injected into the striatum to create a focal abscess 
(Bloch et al., 2005). The immune response was similar in wild type and AQP4 null mice. The 
disruption of the blood-brain barrier is probably secondary to the infectious process with 
release of cytokines and bacterial components into the neuropil. The disruption of the blood-
brain barrier was similar in both groups, assessed by extravasation of Evan’s blue. At day 3 
the AQP4 mice had significantly increased intracranial pressure and brain water content 
compared with the controls.   
The edema following the expansion of a brain tumor may increase the ICP and aggravate the 
neurological deterioration. In astrocytomas, AQP4 is massively up-regulated as judged by 
non-quantitative immunolabelling and the polarization of AQP4 is lost. Hence, AQP4 is 
distributed evenly over the astrocyte membrane. Moreover, increased AQP4 expression is 
seen in reactive astrocytes around metastases of adenocarcinomas (Saadoun et al., 2002).  
 In a mouse model of brain tumor edema, melanoma cells were implanted stereotactically and 
allowed to grow in the brain parenchyma. After 7 days there was greater elevation in ICP and 
more severe neurological deterioration in the AQP4 null mice than in wild type controls, most 
likely due to an impaired removal of brain water (Papadopoulos et al., 2004).  Thus, AQP4 
may be an important modulator of edema resolution in aggressive primary brain tumors as 
well as metastases. The phenotypic impact of AQP4 gene deletion is in line with the studies 
suggesting that the CSF may act as a sink for excess brain water so as to counteract brain 
edema formation (Hochwald et al., 1976). Hence, AQP4 may contribute to the sink function 
of the CSF by its presence in the brain-CSF interfaces. 
Hydrocephalic edema 
In a model of non-communicating hydrocephalus, kaolin was infused into the cisterna magna 
with a subsequent obstruction of the transport of CSF into the subarachnoid space (Bloch et 
al., 2006). In this model, AQP4 null mice showed a more rapid increase in brain edema and 
ICP, yielding a more extensive neurological impairment than the wild type controls. These 
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findings corroborate the proposed role of AQP4 in mediating efflux of CSF when the normal 
drainage routes are compromised, and possibly also under normal physiological conditions.  
To sum up, it turns out that AQP4 has multifarious roles in the pathophysiology of  brain 
edema. In cytotoxic and osmotic edema, AQP4 is likely to increase development of brain 
edema. AQP4 could increase the influx of water through the perivascular membrane directly 
by increasing the permeability coefficient of the blood-brain barrier, but this theory is 
tempered  by the fact that there are presently no known aquaporins in the endothelial cells. In 
ischemia and osmotic edema, a plausible explanation is that AQP4 increases the kinetic of the 
swelling associated with sodium accumulation (cytotoxic) or water (osmotic) and setting up a 
new osmotic gradient forcing water into the brain. However, the possibility remains that 
AQP4 modulates the flux of water through hitherto unknown mechanisms.   
In vasogenic and hydrocephalic edema, AQP4 is likely to increase the resolution of brain 
edema by facilitating  bulk flow of water through the subpial membrane (maybe also the 
perivascular membrane) and the ependymal lining into the subarachnoid space and ventricles. 
These spaces could act as sinks and help shunt fluid out of the cranial cavity through the 
arachnoid villi.  The exact magnitude of bulk flow through these endfeet is currently 
unknown.   
In conclusion, the use of transgenic mice has been crucial in unraveling the 
pathophysiological importance of AQP4 in several models of brain edema.  
However, the temporal dynamics and regulation of AQP4 in vivo in different membrane 
domains in edema formation and other pathologies are largely unexplored. Thus, it is of 
paramount importance to gain further insight into these issues before considering AQP4 a 
candidate for therapeutic intervention.  
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6. HYPOTHESES AND AIMS OF THE STUDY 
AQP4 has a Janus-phased role in brain edema formation, where the pools of AQP4 in 
different membrane domains are likely to have divergent roles in brain edema formation and 
resolution. Hence, we hypothesized that AQP4 must be subject to regulation in CNS disease 
associated with the development of brain edema to 1) decrease the influx of water into the 
brain and 2) increase the efflux of water out of the brain so as to enhance resolution of brain 
edema. Consequently, we hypothesized that AQP4 has separate roles in different membrane 
domains and that these polarized pools of AQP4 will respond differently to osmotic gradients 
and edema formation and must be subject to local regulation.     
Finally, we hypothesized that local differences in anchoring mechanisms are likely to 
influence polarized AQP4 expression and distribution during pathogenesis.  
To unravel the dynamics of AQP4 expression in different membrane domains and the impact 
of AQP4 on brain edema formation in CNS pathogenesis, we have utilized different clinically 
relevant models with edema formation.  More specifically; the subgoals to advance our 
knowledge and challenge our hypotheses were: 
I. To unravel the mechanisms responsible for the polarized expression of AQP4 in 
retinal macroglial cells. 
II. To elucidate the effect of transient ischemia on AQP4 expression and distribution in 
the perivascular endfeet in different brain regions in the infarction core and border 
zone after various reperfusion times. 
III. To explore the polarization and distribution of AQP4 in different brain regions and 
membrane domains after induction of hyponatremia. 
IV.  To develop a  mouse model for bacterial meningitis, suitable for unraveling the role of 
AQP4 in meningococcal meningitis.  
V.  Use this model to investigate the expression of AQP4 in whole brain and different 
membrane domains and the effect of AQP4 deletion on brain edema formation and 
pathogenesis in meningococcal meningitis. 
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7. RESULTS AND CONCLUSIONS
Paper I
Differential effect of alpha-syntrophin knockout on aquaporin-4 and Kir4.1 expression in 
retinal marcoglial cells in mice.  
The expression of AQP4 in the perivascular endfeet in brain is dependent on -syntrophin, as 
less than 10% of perivascular AQP4 remained in -syntrophin KO mice. Thus, we wanted to 
investigate if another part of the CNS, the retina, displayed similar anchoring mechanisms and 
also to generate new hypotheses about anchoring of AQP4 and Kir4.1. 
In the retina, the expression of AQP4 was higher in the perivascular membranes, than 
subvitreally, indicating enrichment in the former membrane domain.   
Deletion of the -syntrophin gene caused a significant loss (70%) of AQP4 in the perivascular 
and subvitreal membrane, as judged by quantitative analysis of the linear gold particle 
density. In wild type animals, the labeling of Kir4.1 was more intense in endfeet membranes 
than other membrane domains. Moreover, there was no reduction in the Kir4.1 labeling 
intensity in -syntrophin KO mice. On the contrary, the perivascular membrane domains 
showed a statistically significant increase in Kir4.1 immunolabeling following gene deletion 
of -syntrophin.  
With the use of selective antibodies, we were able to show that another member of the 
syntrophin family, 1-syntrophin, is heavily expressed in the perivascular and subvitreal 
membranes of both wild type and -syntrophin KO mice. Finally, deletion of -syntrophin did 
not cause any up- or downregulation of 1-syntrophin. 
We conclude that in the retina, the polarized anchoring of AQP4, but not Kir4.1, is dependent 
on -syntrophin.  
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Paper II
Temporary loss of perivascular aquaporin-4 in neocortex after transient middle cerebral 
artery occlusion in mice.  
Ischemic stroke is the third leading cause of death and the concomitant brain edema 
contributes by increasing the intracranial pressure and making the patient vulnerable to 
herniation. As the ischemic event progresses, the astrocytes become unable to regulate ionic 
gradient that is crucial in glial physiology. Hence, uptake of water via AQP4 in the 
perivascular endfeet will inevitably yield a cytotoxic edema. Thus, we wanted to explore the 
effect of ischemia on the -syntrophin dependent perivascular pool of AQP4 (paper I and 
(Amiry-Moghaddam et al., 2003a) in the infarction core and the less affected border zone.    
By utilizing a well established stroke model in mice (MCAO) it was found by quantitative 
immunogold cytochemistry that the ischemic striatum and neocortex show distinct patterns of 
AQP4 expression in the reperfusion phase after 90 min of middle cerebral artery occlusion. 
The striatal core displayed a loss of perivascular AQP4 at 24 h of reperfusion with no sign of 
subsequent recovery. The most affected part of the neocortex also exhibited loss of 
perivascular AQP4, but showed a tendency towards recovery at 72 h of reperfusion.  
The cortical border zone differed from the central part of the ischemic lesion by showing no 
loss of perivascular AQP4 at 24 h of reperfusion, but rather a slight increase. 
Theoretically, the remarkable reduction in the immunosignal could be due to conformational 
changes in the AQP4 protein, decreasing the antigenity of the epitope. 
This possibility was ruled out by employing freeze fracture electron microscopy where the 
perivascular membrane of the infarction core showed a dramatic reduction of OAPs. 
We then investigated if also -syntrophin was downregulated or redistributed in ischemia.  
However, the -syntrophin labeling in the perivascular membrane was intact in the infarction 
core and therefore not compatible with a general disruption of perivascular plasma 
membranes. Thus, the interaction between AQP4 and -syntrophin seems sensitive to severe 
ischemia as the expression of AQP4 was largely unchanged in the less affected border zone.  
We conclude that the size of the AQP4 pool in the perivascular membrane  
is subject to large and region-specific changes in the reperfusion phase.  
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Paper III
Dynamic changes in brain aquaporin-4 distribution 
in mouse brain after induction of hyponatremia 
Having explored the dynamics of AQP4 in ischemia with subsequent reperfusion in paper II, 
we wanted to explore more selectively the impact of edema on the expression of AQP4 in 
different domains and with different anchoring mechanisms (cf. hypotheses above). 
Hyponatremia will inevitably create an osmotic gradient between blood and brain. 
Thus, this condition is uniquely relevant for studying the impact of an osmotic gradient 
change on AQP4 distribution. 
An electron microscopic analyis of mice sacrificed after acute induction of hypotonic 
hyponatremia (HN) revealed striking differences in 1) AQP4 immunolabelling between the 
neocortex and the cerebellar cortex and 2) immunolabelling in different membrane domains 
within the same brain region.   
Notably, the neocortex demonstrated a significant increase (64%) in the labelling in the 
subpial membrane after 20 min HN that was followed by a significant drop (41%) in the 
labelling after 120 min HN. At 4 h after onset of hyponatremia an immunoblot analysis 
revealed that the protein levels of AQP4 was reduced significantly in the superficial parts of 
the neocortex, while no changes where observed in the deeper layer or at earlier time points.      
However, in the cerebellar cortex the density of gold partices was increased (by 44%) in the 
astrocyte membranes in the neuropil in the granule cell layer after 45 min HN. Strikingly, the 
astrocytic membrane in the neuropil in the granule cell layer had significantly less labelling 
(23%) after 120 min compared with 45 min HN.  
We conclude that the immunoreactivity of AQP4 is heavily dependent on brain region, 
membrane domains and time course after induction of hyponatremia. 
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Paper IV
Brain inflammation in wildtype and aquaporin-4 null mice in 
meningococcal meningitis model 
Prompted by the results from the two functional studies, we decided to look at AQP4 
expression in yet another model with concomitant edema, namely meningococcal meningitis. 
However, in the absence of a suitable model for meningococcal meningitis, we were forced to 
develop our own.  
AQP4 has been reported to be massively upregulated in pneumococcal meningitis 
(Papadopoulos and Verkman, 2005). We established a model to study the impact of 
meningitis on AQP4 expression and also the impact of AQP4 on the water balance in 
meningococcal meningitis.  
Three mice strains (CD1, C57BL/6 and AQP4 null mice in a C57BL/6 genetic background) 
were subjected to intra-cerebrospinal fluid (CSF) injection of N. meningitidis serogroup B or 
PBS as a negative control. Some mice were injected with S. pneumoniae or 
lipooligosaccharide (LOS). 
An electron microscopic analysis showed massive infiltration of granulocytes on the pial 
surface. There was focal clustering of meningococci attached to the pial surface.  
Further, the mice showed sign of sickness as locomotion was decreased considerably. The 
expression of Tnf- was increased severalfold as a sign of severe inflammation.  
In mice with Mc the Tnf- expression levels were increased after 9 hours, predominantly in 
the core brain, but after 30 h the inflammation was mostly confined to the brain surface and 
locomotion in these mice was also severely reduced. However, in Pc animals Tnf- was 
increased in the brain surface at 9 and 24 h.  In LOS injected mice, Tnf- was increased at the  
brain surface and in core brain at 9 h. On the contrary, at 30 h Tnf- was increased 
predominantly in the core brain. The neuropathological assessment of mice injected with 
PBS, Mc, Pc or LOS revealed that in general there was a correlation between brain 
inflammation by histopathology, high Tnf- gene expression and reduced locomotion.  
We conclude that the mice in this model infected intracisternally with N. meningitidis, 
develop clinical meningitis that shows resemblance with the pathogenesis in humans.  
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Paper V  
Brain water imbalance and aquaporin-4 expression in
 a mouse model for bacterial meningitis 
Here we utilized the model in paper IV to first gain insight into the brain edema formation in 
this model and then investigate the expression of AQP4 in meningococcal meningitis.  
In CD1 mice there was a significant increase in brain water 24 h after injection of meningocci.  
Surprisingly, C57BL/6 mice injected with Mc did not have increased brain water.   
Unexpectedly, 24 h after injection brain water was increased significantly in AQP4 KO mice 
infected with Mc, compared with AQP4 KO mice injected with PBS.  
Prompted by this, we decided to explore the effect of strict temperature control on brain water 
formation. Intriguingly, brain water was now significantly increased in C57BL/6, thus, 
pointing to an effect of temperature on edema development in meningococcal meningitis. 
Yet again, the brain water in AQP4 null mice infected with Mc was increased more than in the 
other mice strains, displaying a massive 1% increase in brain water.  
As AQP4 was reported to be tremendously increased in a previous work in mice infected with 
S. pneumoniae, we undertook a thorough analysis of AQP4 protein and gene expression in 
mice infected with Mc or Sp. However, none of our analyses showed any signs of 
upregulation of AQP4 in meningococcal or pneumococcal meningitis. 
Thus, the gene expression of Aqp4 seemed to be unaltered or only modestly changed in Mc 
and Pc meningitis. Interestingly, however, the gene expression of Aqp4 was increased 
severalfold (4 x) in the core brain at 9 and 30 h in the mice with LOS injection as compared to 
the negative controls. Our immunoblot analysis revealed that AQP4 was decreased in mice 
infected with N. meningitis for 24 h (36%) and S. pneumoniae for 30 h (44%, P < 0.03). 
We conclude that the brain water is increased, in a temperature-dependent manner and 
mice lacking AQP4 accumulate more brain water than wildtype mice in meningococcal 
meningitis. 
Finally, the AQP4 expression is not increased in Mc or Pc mice, but seems on the contrary to 
be modestly downregulated in mice infected with N. meningitidis or S. pneumoniae.  
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8. DISCUSSION
8.1 Impact of results
The present study has provided new insight into the dynamics of AQP4 in pathophysiology.  
We have shown that AQP4 pools in different parts of the brains and in specific membrane 
domains display unique expression patterns and are presumably subject to local regulation in 
pathophysiology (cf hypotheses).    
  
-Syntrophin dependent anchoring of AQP4 in retina 
We have previously shown that AQP4 is dependent on -syntrophin for its anchoring in the 
perivascular endfeet in the brain (Neely et al., 2001).  
In the retina our results revealed that AQP4, but not Kir4.1, is dependent on -syntrophin for 
its anchoring in the subvitreal or perivascular membrane, displaying a ~70% decrease in the 
-syntrophin KO mice. However, there is possibly a pool of AQP4 that is insensitive to -
syntrophin gene deletion, as the dependency of -syntrophin in the perivascular membranes in 
brain is over 90%. Moreover, we also found strong expression of 1-syntrophin in the 
aforementioned membrane domains and it is tempting to speculate that 1-syntrophin could 
be responsible for the proposed -syntrophin independent pool in the perivascular – and 
subvitreal membranes in the retina. Our findings are partly corroborated by studies with Dp71 
KO mice, lacking the main glial dystrophin isoform, where AQP4 is redistributed and the 
expression markedly reduced in the retina, whereas the expression of Kir4.1 is unchanged 
(Dalloz et al., 2003; Fort et al., 2008). However, -syntrophin expression was unchanged, thus 
not directly dependent on Dp71 for its expression in the retina.
If -syntrophin is unchanged why is AQP4 reduced if dependent on -syntrophin (present 
study)? Biochemical analysis has given some clues as -syntrophin is unable to pull down 
AQP4 without a cross-linker (Neely et al., 2001). Thus, the interaction is probably dependent 
on an intermediate molecule (here called protein X).  
The expression and anchoring of protein X should be dependent on the coexpression of Dp71 
and -syntrophin. Thus, in Dp71 KOs the loss of interaction between Dp71 and -syntrophin 
could destabilize protein X and AQP4 and vice versa with the -syntrophin KOs.  
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In the Dp71 KOs utrophin, a homolog to dystrophin, was increased severalfold, indicating 
that -syntrophin may interact with utrophin in the absence of Dp71, as utrophin has strong 
affinity to -syntrophin in biochemical analysis (Fort et al., 2008).   
We have previously hypothesized that Kir4.1 and AQP4 may act in concert in the uptake of 
water and potassium after neuronal depolarization. Our functional analyses of  the -
syntrophin KO model could be seriously confounded if Kir4.1 was  massively dislocated from 
the perivascular membrane, along with AQP4. 
In our study we did not distinguish between the Müller cell endfeet and the astrocyte endfeet 
processes. Neither did we distinguish between capillaries in different layers of retina. We can 
not rule out that the syntrophin dependency of AQP4 or Kir4.1 differs between  cell types 
(Müller cells vs. astrocytes) or between retinal layers. 
AQP4 undergoes major changes after ischemic stroke 
In paper II we demonstrated that the -syntrophin dependent perivascular pool of AQP4 is 
temporarily lost after middle cerebral artery occlusion (MCAO).  
These findings bear on the molecular mechanisms underlying the generation and resolution of 
postischemic edema. Since AQP4 in the perivascular membrane allows bidirectional water 
flow, this pool is likely to be rate limiting for water influx as well as efflux. In the early 
ischemic event, the edema mechanism is largely cytotoxic. Later, disruption of the blood-
brain barrier will lead to development of vasogenic edema. Thus, the initial downregulation of 
the perivascular pool should be beneficial in the early event and impede influx, while later in 
the time course the partial recovery of AQP4 expression would be expected to favor the 
resolution of the edema.  
Our conclusion is that the loss of AQP4 immunogold signal from perivascular membrane 
reflects a loss of AQP4 molecules from these membranes. Alternatively, the observed 
reduction in AQP4 immunolabelling could be due to conformational changes of the epitope, 
reducing its affinity to the antibody. One must also consider the possibility that the reduction 
in the immunosignal is non-selective and caused by a general disruption of the astrocytic 
plasma membranes in the postischemic phase. Both of these alternative explanations can be 
ruled out by supportive experiments.  
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Notably, in collaboration with Dr. John Rash and coworkers we were able to demonstrate a 
clear reduction in the number of perivascular orthogonal arrays (OAPs) in the infarction core 
at 24 h of reperfusion. This is consistent with loss of AQP4 rather than changes in the 
conformation of this molecule. Further, our finding of persistent -syntrophin labeling in the 
perivascular membrane is not compatible with a general disruption of perivascular plasma 
membranes.   
We do not know the mechanisms that underlie the postischemic loss of AQP4. A plausible 
explanation is that the coupling between AQP4 and -syntrophin is sensitive to ischemia. 
Thus, changes in the microenvironment (e.g. acidification, calcium influx or oxidative 
processes) may weaken the affinity between these two molecules. Following disruption of its 
anchoring, AQP4 would diffuse laterally in the astrocytic plasma membrane. As the 
perivascular membrane is small compared to the total astrocytic surface the loss of AQP4 
from endfoot membranes will not necessarily lead to a detectable increase in the AQP4 
labelling in non-endfoot membranes  
The MCAO model reveals pronounced differences between the cortical and striatal parts of 
the infarcts when it comes to the changes in AQP4 expression after MCAO. These differences 
probably reflect the fact that striatum is more severely affected than the cortex following 
ligation of the middle cerebral artery. This is also consistent with clinical findings. The 
observation that the perivascular pool of AQP4 is lost in the infarction core could at first sight 
seem disappointing as one might argue that this will reduce the usefulness of AQP4 as a 
potential target. However, the target for modern stroke therapy is primarily in the border zone, 
where most of the cells are viable, but in a dormant state. AQP4 is not downregulated in the 
border zone, rather there is a tendency towards upregulation. Blockage of AQP4 in the border 
zone of the infarcted area could very well decrease the secondary water influx associated with 
cytotoxic edema and thus the size of the infarction core. Immediate action with blockage of 
AQP4 could also minimize the infarction core.   
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Dynamic and membrane-specific changes of AQP4 in hyponatremia  
In paper III we explored the influence of osmotic gradient on AQP4 distribution in different 
parts of the brain and membrane domains in a mouse model of acute hyponatremia.   
Our results show that the neocortex responds to hypotonic hyponatremia by a short-term 
upregulation in the subpial membrane, while in the cerebellar cortex  there is an upregulation 
in the granule cell layer. These changes are short lasting as there is reduced immunoreactvity 
for AQP4 after 120 min HN in the same membranes. An immunoblot analysis showed no 
differences in AQP4 immunoreactivity at 20 min, 120 min or 240 min of hyponatremia in the 
upper or deeper layers of the cerebellum, compared with the control animals, thus, it is 
unlikely that de novo protein synthesis could explain the observed short-term term 
differences. On the contrary, the immunoblot analysis revealed a significant decrease in the 
superficial parts of the neocortex at 4 h following induction of hyponatremia (P < 0.05). 
  
A previous study showed a modestly increased AQP4 by immunoblot in whole brain and 
cerebellum in rat after 4 h after acute hyponatremia (Vajda et al., 2000). The discrepancy 
between the latter study and ours  could be due to sampling (whole brain vs. cortical layers), 
species differences, or differences in the experimental protocols (2.5% Glucose solution vs. 
only water). 
Proposed mechanism for short-term regulation 
These early changes in immunolabelling after hyponatremia are likely to reflect either 
redistribution of AQP4 between membrane domains, vesicular intracellular transport or 
conformational changes altering the antigenicity. 
The immunogold analysis showed a tendency, albeit modest, towards less labelling in the 
deeper layer of the cortex and the upper layers of the cerebellum.  
However, the immunoblot analysis showed no changes in anti-AQP4 immunoreactivity 
between the superficial and deeper neocortical layers. Thus, a redistribution between layers is 
less likely. However, due to methodological constraints the dissected slices for immunoblot 
analysis were composed of several layers, thus limiting the comparability to the immunogold 
analysis. 
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The short-term regulation of AQP4 has been shown to be dependent on endocytotic pathways 
and the action of several kinases (Madrid et al., 2001; Carmosino et al., 2007). Thus, our 
results could plausibly be explained by decreased internalization of AQP4 or release from 
cytosolic vesicles. The dynamics of the AQP4 trafficking and recycling along the endocytic 
pathway in vivo is currently unknown 
Hypertonic stress has been shown to increase the internalization of AQP4 in cell cultures 
(Madrid et al., 2001; Arima et al., 2003). On the other hand, hypoosmotic stress increases 
vesicle recycling in Intestine 407 cells (van der et al., 2003), but the effect of hypotonicity on 
endocytosis in glia and thus of AQP4 expression is currently not known. In Xenopus laevis
oocytes activation of the V1aR with PKC dependent phosphorylation of serine 180  increased 
internalization of orthogonal arrays (OAPs) of AQP4 (Moeller et al., 2009). Thus, the 
expected decrease in AVP after induction of hyponatremia may dephosphorylate serine 180 
and temporarily impede the internalization of AQP4.  
Previous studies have indicated that brain could be under a tonic stimulation of AVP under 
physiological conditions (Niermann et al J. Neuroscience 2001) 
The immunogold analysis revealed sparse intracellular labelling of AQP4 
Thus, unlike the situation for AQP2 in the kidney, there is as yet no evidence for the existence 
of a significant vesicular pool of AQP4. Nevertheless, we cannot rule out that endosomal 
acidity and the adaptor proteins involved in clathrin-dependent endocytosis interacting with 
the C-terminus could shield the antigen from immunodetection. Recently, increasing data has 
elucidated the dynamics of OAP formation and disruption, where the M1/ M23 ratio regulates 
the size of the OAPs (Crane and Verkman, 2009; Crane et al., 2009a; Crane et al., 2009b). 
Consequently, the size of the OAPs could hypothetically alter the antigenicity through steric 
hindrance. Phosphorylation of residues in the C-terminus could also alter the conformation 
and immunolabelling of AQP4. 
Finally, hypoosmotic stress has been shown to increase the extracellular concentration of 
glutamate, that may elicit Ca2+ wave propagation by activation of glial mGluRs.  
Interestingly, a recent study has shown that glutamate induced calcium release may rapidly 
increase the water transport through AQP4 mediated by a CaMKII dependent phosphorylation 
of serine 111 (Gunnarson et al., 2008). Thus, glutamate is a prime candidate to be involved in 
regulation of AQP4 distribution and function in hyponatremia.  
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Proposed  impact of rapid changes in AQP4 distribution on brain edema formation   
Interestingly, those subpial membrane in the neocortex and granule cell layer in the cerebellar 
cortex that both displayed fast, dynamic changes are not dependent on -syntrophin or 
dystrophin for the polarization of AQP4 (Amiry-Moghaddam et al., 2004b; Nicchia et al., 
2008). Further, these membrane domains could be  important efflux routes for bulk flow of 
water and osmolytes, when osmotic gradients force water into the brain. The surface area of 
the subpial membrane is significantly smaller than the total surface area of all the perivascular 
endfeet. Hence, regulation of water transport is probably even more important in the subpial 
membrane.  
The observed differences in the short-term regulation of AQP4 could be a product of potential 
differences in the edema resolution between the neocortex and cerebellum.  
The induction of hyponatremia will inevitably create a strong osmotic gradient that will force 
water into the brain. The main point is what implication this new finding might have in regard 
to the understanding of the directions of water after brain edema.  
Several lines of evidence suggest that the initial, rapid response to acute hyponatremia is an 
increase in interstitial pressure, leading to shunting of fluid and solutes (i.e. Na+ and Cl-) from 
the interstitial space into the cerebrospinal fluid via the subpial membrane or ependyma and 
then into the systemic circulation (Melton et al., 1987). Hence, an ultra-fast upregulation of 
AQP4 in this domain in the neocortex would potentially increase the capacity for filtration of 
water and electrolytes (by increasing the permeability coefficient) through the subpial endfeet 
as a fast adapting, protective mechanism.  
The brain also responds rapidly to hyponatremia by releasing K+  and organic osmolytes (e.g 
taurine and myo-inositol) from neurons for subsequent uptake in  adjacent glia (Lehmann et 
al., 1991). This mechanism only shifts volume from neurons to glia and represents no net 
change in brain water. Eventually, K+ and the organic osmolytes are lost from the brain via 
perivascular glia. These changes  will also contribute to reducing the osmotic gradient and 
impede the build-up of brain edema (Thurston et al., 1975; Sterns et al., 1993).  
In conclusion, our data suggest that induction of hyponatremia elicits fast changes in AQP4 
expression or conformation and that there are significant regional differences in response to 
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hyponatremia. These changes may reflect the observed differences in edema formation 
between brain regions.  
Our main finding is that the subpial membrane undergoes a significant upregulation of AQP4 
shortly after the onset of hyponatremia. A likely mechanism is that the decreased AVP will 
decrease the internalization of AQP4 and maybe also increase exocytosis. 
Hence, this mechanism would make physiological sense as increased AQP4 may increase the 
efflux into the subarachnoid space that acts as a sink and decrease brain water content in 
hyponatremia (Hochwald et al., 1976).  
Mouse model for bacterial meningitis  
In order to further characterize the expression of AQP4 in CNS pathophysiology and the 
impact of AQP4 in brain edema formation we established a mouse model for bacterial 
meningitis in paper IV. In the presented model, N. meningitidis was infused into the CSF 
through an incision in the skull near the bregma. Addition of iron to the infusate selectively 
enhanced the development of meningitis rather than sepsis. 
As N. meningitidis is not normally a pathogen in mice, the extrapolation from experimentally 
induced meningitis in mice to clinical meningitis in man is a daunting task. 
However, the mice showed a plethora of signs consistent with clinical meningitis.  
The immune system was activated as expression of Tnf-, a marker for severe inflammation, 
was increased severalfold. Further, streaking of CSF samples produced colonies of Mc on 
blood agars. The mice showed fever, reduced locomotion, fatigue and weight loss; all clinical 
signs of meningitis.  
The Tnf- gene expression was increased in mice infected with Mc after 9 hours, but only in 
the core brain. However, after 30 h the inflammation was mostly confined to the brain 
surface. One explanation for this counterintuitive finding is that shortly after Mc infection 
there is no predominant meningitis, but a general, global inflammatory response. The 
pathoanatomic analysis did not reveal visible inflammation in the brain or meninges after only 
9 h. The Tnf- upregulation could be mainly due to blood in the brain, thus not really a 
cerebral inflammation. 
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However, after 30 h almost every animal with MC show meningeal inflammation as a sign of 
meningitis. Consequently, Tnf- is also increased at the brain surface.     
As the bacteria were directly inoculated into the CSF, this model does not enable the 
investigation of the crucial pathophysiological steps from a commensal microbe in the upper 
airways and the subsequent interaction with the blood-brain barrier and the penetration into 
the brain, yielding meningitis. This notwithstanding, we believed that the model could be an 
excellent tool for exploring the host-pathogen interaction of a specific number of defined 
bacteria after penetration into the brain.  
Impact of AQP4 gene deletion on brain edema formation in meningococcal meningitis  
In paper V we utilized the model presented in paper IV to study the impact of infection with 
N. meningitidis on AQP4 expression and brain water dynamics in wild type mice and AQP4 
null mice. Currently, there seems to be uncertainty as to the prevalence and mechanism of 
brain edema in meningococcal meningitis. Diffusion-weighted MRI data suggest that the 
early edema formation in meningococcal meningitis is primarily cortical and cytotoxic (Citton 
et al., 2009). 
Interestingly, the degree of concomitant bacteremia seems to modulate the formation of brain 
edema, at least in pneumococcal meningitis (Brandt et al., 2008). Loss of cerebral 
autoregulation is also common in acute bacterial meningitis: Increasing the ICP and the 
hydrostatic driving force for water into the CNS (Pedersen et al., 2007).  
Acute inflammation of the meninges is also likely to increase the resistance of cerebral fluid 
outflow through the subpial membrane and ependymal lining and a degree of hydrocephalic 
edema is expected.  In these circumstances, AQP4 could be critically involved in the 
resolution of the edema by facilitating bulk flow through these natural efflux routes.  
The facts that we observed an increase in brain water in AQP4 KO after induction of 
meningococcal meningitis, and that the blood-brain barrier seemed to be intact in the mouse 
meningitis model, are not consistent with an early cytotoxic edema only, but more in line with 
a component of hydrocephalic edema.  
Unexpectedly, we found no evidence for up-regulation of AQP4 in pneumococcal or 
meningoccal meningitis. Moreover, a quantitative immunoblot revealed a significant decrease 
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in AQP4 immunolabelling in mice infected with S. pneumoniae for 30 h. These findings are in 
clear contrast to the reported severalfold increase in AQP4 expression after pneumoccal 
meningitis (Papadoupoulos and Verkman, 2005). Moreover, in another study, 
intracerebrospinal administration of IL-1 led to a significant upregulation of AQP4 (Ito et 
al., 2006). Interestingly, inhibition of the nuclear factor-B pathway abolished the induction 
of AQP4. Our finding that the gene expression of AQP4 was increased 4-fold in mice injected 
with lipo-oligosaccharide (LOS) for 9 and 30 h in the core brain, but not in the brain surface, 
is intriguing. Hence, it could be that astrocytes near the brain surface respond differently to 
LOS than astrocytes in the core brain.  
In the previous study (Papadopoulos and Verkman, 2005), also a model with direct 
inoculation, the design was much rougher with the needle penetrating the parenchyma before  
depositing the bacteria into the basal cisterna. This is likely to cause tissue damage and 
bleeding which could hypothetically in combination with S. pneumoniae alter AQP4 
expression. One must also keep in mind that the cell wall components of S. pneumoniae and  
N. meningitidis (peptidoglycan and LOS, respectively) activate partly different cascade 
systems, in addition to the common effects through IL-1. 
Vasopressin is often significantly elevated in bacterial meningitis (Leclerc et al., 2003). There 
is experimental evidence that elevated vasopressin, activating its receptor ( V1aR),  and 
phosphorylation of serine 180 by PKC, increases internalization of OAPs (Moeller et al., 
2009). Nevertheless, the precise mechanisms for regulation of AQP4 in meningitis are still 
obscure and warrant further studies.  
Overall conclusion
The present study has shown that AQP4 expression is dynamic and that the  
response of AQP4 to experimental insults or disease differs between brain regions and 
membrane domains (cf. hypothesis), probably as a consequence of  different anchoring 
mechanisms (cf. hypothesis).  
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8.2 Methodological considerations
The overriding goal of this thesis was to explore the expression and polarization of AQP4 
during pathogenesis. AQP4 can be visualized by several methods, but only electron 
microscopy has good enough resolution to show that AQP4 is selectively polarized in 
astrocytic endfeet and not in the adjacent epithelial membrane (Nielsen et al., 1997).  
Postembedding electron microscopy 
The hallmark of postembedding immunocytochemistry is that the tissue is embedded in a 
resin prior to the immunocytochemical procedure followed by an electron microscopic 
analysis. The ultimate goal in postembedding immunocytochemistry is to achieve a 
representative ultrastructure of the tissue combined with efficient labeling of the proteins of 
interest. In practice, the first desire conflicts with the latter.  
The resolution of the postembedding method is restricted only by the length of the antibody 
bridge and the diameter of the gold particle. In theory, the distance between the gold particle 
and the epitope should correspond to the radius of the gold particle plus the length of the 
interposed immunoglobulins. Using 15 nm gold particles and a primary and secondary IgG 
(each with a length of 8 nm) this distance should be roughly 23 nm.  
To obtain excellent specificity it is very important to keep background labeling at a minimum.   
Since immunoreagents tend to show low-affinity, unspecific binding to  tissue proteins it is 
important to add some proteins to the buffer solutions to block this binding. 
Usually, with 2% HSA included in the solution we obtain very low background labeling 
combined with a strong specific signal.  
The postembedding technique only allows immunodetection of those antigens that are 
exposed at the surface of the section. This implies that the proportion of antigen available for 
immunodetection is severely restricted compared to other immunocytochemical approaches. 
Many parameters in the incubation protocol may affect the strength of the immunogold signal. 
On a general basis, the signal is strengthened with increased concentration of the primary 
antibody and reduced concentration of saline. However, with high antibody concentrations 
there is also a risk for increased unspecific binding. Careful experimentation is required to 
identify the conditions that give the highest signal-to-noise ratio for a given antibody.  
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When the labeling efficiency and specificity are high the postembedding method is 
semiquantitative and a near linear correlation exists between antigen concentration and 
immunosignal (Ottersen, 1989). Luckily, we have thus far been granted with very good 
commercial anti-AQP4 antibodies, yielding strong labeling (sensitivity) with minimal 
background labeling,    
Sampling of the material for the electron microscopic analysis
In all the capturing of the electron microscopic pictures the investigator has been blinded to 
the tissue on the examined grids. In our lab, the technicians at the lab reorder the grids by a 
written code in the grid box unaware of the tissue on the grids. The images are also analyzed 
blinded to the investigator. Thus, because the investigator is unaware of exactly the grids this 
should rule out a lot of the potential bias. 
In paper II and paper III we have discriminated between different regions and layers in our 
analyses. In paper I the sampling in retina did not discriminate between the different layers 
and regions (central/ peripheral) or between the different glial cells (Müller cells vs. 
astrocytes). As retina consists of several different layers, we can not rule out regional 
differences in the retina.  
Image capturing and image analysis
In the subsequent electron microscopic analysis it is important to choose an electron optic 
magnification that represents a good compromise between digital resolution, required field of 
view and the size of the digital image file.  
Our main tool for quantifying immunogold labeling is ANALYSIS, created in our laboratory 
(Haug et al., 1994; Haug et al., 1996) in collaboration with Soft Imaging Systems Gmbh in 
Germany as an extension to their commercial software.  
In brief, transected organelles are drawn freehand as regions of interest (ROIs) and 
membranes as curves. As already discussed the theoretical distance between the antigen of 
interest and gold particle is approx. 23 nm. We usually sample gold particles within 30 nm of 
either side of the membrane. Particles further away from the membrane are eliminated. Gold 
particles along a curve (i.e. membrane) are measured as linear densities, while gold particles 
in a ROI are measured as areal densities. For instance, in the analysis of perivascular AQP4 
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expression, the ROI is the “perivascular endfeet” and the curve of interest is the “perivascular 
membrane”.  
Although the calculation of gold particles is done automatically, it is necessary to carefully 
inspect the results and optimize the parameters, if required. In some cases one has to 
interactively delete, add, or split particles. Thus the quality of the quantitative analysis 
depends on the skills of the operator. In ANALYSIS, an image with associated ROIs, curves, 
and particles is termed a field. Finally, linear density of particles per curve and areal density 
of particles per ROI are aggregated over the project and exported to SPSS, and the fields are 
subjected to statistical analysis. 
Freeze-fracture electron microscopy 
In brief, in the freeze-fracturing method the specimen is fixed in formaldehyde, frozen in 
liquid nitrogen, and then fractured by a knife in vacuum. Carbon-platinum replicas of the 
fracture faces are made by shadowing the surface at narrow angles and then digesting away 
the tissue. When the replicas are examined in the electron microscope, it is seen that cell 
membranes caught in the cleavage plane are split down the middle of their lipid layer where 
the molecular binding is weakest. This exposes one of two complementary faces: the P face, 
which represents the external aspect of the inner cytoplasmic leaflet, and the E face, which 
represents the internal aspect of the outer cytoplasmic leaflet. The true inner and outer 
surfaces of the plasma membrane are not exposed by this method.  
In mammals, proteins generally adhere to the P face, whereas “pits” in the E face represent 
imprints of the membrane protein. The assemblies of proteins seen in the P- and E- face are 
called intramembrane particles (IMPs). 
Interestingly, early freeze fracture studies revealed abundant “square arrays” of IMPs in 
freeze-fractured membranes of astrocytes, called OAP (orthogonal array of particles) 
(Dermietzel, 1974). AQP4 KO mice lacked OAPs in the plasma membrane of astrocyte 
endfeet and in other AQP4 expressing tissues and we now know that OAPs is in fact 
orthogonal arrays of AQP4 tetramers (Verbavatz et al., 1997; Rash et al., 1998). 
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Real-time PCR of Aqp4 and Tnf-
The procedure follows the general priniciple of a polymerase chain reaction, but the key 
feature is that RNA is isolated, converted to cDNA and the amplified cDNA is detected in real 
time as the reaction progresses.  
This unique advantage makes the method quantitative. The amplified DNA may detected by a 
non-specific fluorescent dye intercalating with DNA or sequence-specific DNA probes that 
are labelled with a fluorescent reporter. We have utilized the non-specific SYBR Green dye. 
However, this dye will bind to all dsDNA PCR products, such as primer dimer, and this can 
potentially prevent accurate quantification of the intended target sequence.  
The values obtained by the PCR instrument have no absolute unite, but can only give a 
fraction or ratio relative to a standard.  
Further, the relative concentrations of DNA during the exponential phase of the reaction are 
plotted against a logarithmic scale. The cycle where the fluorescence crosses this straight line, 
is called the cycle threshold (Ct). Thus, a sample whose Ct is 4 cycles earlier than another’s 
has 24 = 16 times more template.  
In paper IV and paper V, PCR was performed in four parallel reactions for each gene studied, 
per animal studied. The purity of the amplified product was confirmed with the dissociation 
curve and gel electrophoresis of selected samples. Relative quantitation was achieved by 
using the comparative CT method. In order to correct for differences in the amount and quality 
of cDNA added to the reaction, the housekeeping gene Gapdh was used as an endogenous 
reference, and the results for Aqp4 and Tnf- were normalized to those from Gapdh PCR in 
individual samples. Results were then normalized to a calibrator sample, and the relative 
expression was obtained, providing indirect information on target mRNA levels. 
Immunoblotting of AQP4 
Good resolution could also be a disadvantage: It is difficult to quantify the total levels of 
AQP4 in brain, irrespective of glial domains. In hyponatremia and meningitis we were 
interested in the total amount of AQP4 in brain. Thus, here the method of choice is SDS-
PAGE (paper III and paper V). Proteins can here be measured by quantifying the density of 
the protein bands on a blot. However, the method has great internal variability and the result 
from one experiment is often difficult to replicate. But with care and concern of the most 
common pitfalls the reproducibility will eventually be satisfying.  
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1) The amount of protein loaded should be in the linear range of the standard curve. 
It is of utmost importance that the protein concentrations in samples are accurately measured 
so that the total protein loaded in each lane is equal. First the protein concentrations in the 
samples are measured in triplicate with a spectrophotometer. The separation of proteins on the 
gel is primarily dependent on their molecular weights. The difference in molecular weight of 
the two isoforms of AQP4 is only 2 kDa and to increase the resolution 9 M urea was added to 
the gels.  
2) The transfer from gel to membrane has high variability between gels, but also on the same 
gel, the transfer may be unequal. Thus, it is of paramount importance to repeat the 
experiments.  
3) The incubation of the membrane in primary and secondary antibodies is a critical step.  
The antibody concentration should ideally be titrated on a dot plot membranes.  
However, it is of crucial importance that the membranes are blocked with milk powder before 
incubation with antibodies.  
4) The membranes are incubated in secondary alkaline phosphate-linked immunoglobulin, 
followed by addition of ECF substrate. The alkaline phosphatase catalyzes the conversion of 
ECF substrate to a highly fluorescent product which fluoresces strongly at 540-560 nm. The 
strength of the individual bands may be analyzed and quanitied with commercial available 
image programmes (e.g. Image Quant, GE Health). The strength of the ECF reaction has a 
linear correlation with the amount of proteins in the samples as long as the signal is not 
oversaturated.  
5) After the first incubation with anti-AQP4 antibodies and subsequent analysis it is 
paramount to reprobe with antibodies against a structural housekeeping gene, such as -actin, 
to adjust for unequal protein loading.  
Brain water measurement  
In paper V we wanted to get an objective measurement of brain edema formation. To measure 
brain water we employed the wet/dry-methodology. Thus, the brain is weighed in a pre-
weighed glass beaker on an analytical balance, dried for 24 h at 80°C in a vacuum oven. The 
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dried tissue is reweighed and the total brain water may be computed by the equation (wet 
brain (mg) – dry brain (mg)/ wet brain mg). The method has several pitfalls. It is of outmost 
importance that the brains are removed and homogenized in the same way. An 80°C 10 gram 
glass beaker will have a slight decrease in mass, but this can give an inaccuracy of 2-3% on 
the brain water measurements. Thus, the glass beaker should cool to room temperature.  
Middle cerebral artery occlusion (MCAO) 
In paper II we aimed at exploring the expression of AQP4 after ischemia. We chose to use a 
validated mouse model. MCAO is a stroke model in rodents and mimics the effects of a stroke 
in human. In brief, the skin was opened with a midline incision and the underlying 
submandibular gland and omohyoid muscle where dissected to reveal the common carotid 
artery. Then, the external carotid artery was ligated distally and divided. Next, aneurysm clips 
was applied to the internal carotid artery and common carotid artery. Finally, a 5-0 nylon 
filament was advanced through the external carotid artery stump through a point 6 mm distal 
to the carotid bifurcation. The occlusion of the middle cerebral artery was verified at 30 min 
by allowing the animal to awaken and performing neurological deficit scoring as follows: 0, 
normal motor function; 1, flexion of torso and of contralateral forelimb upon lifting by the 
tail; 2, circling to the contralateral side but normal posture at rest; 3, leaning to the 
contralateral side at rest; 4, no spontaneous motor activity. Mice with clear neurological 
deficits (score of   2) were reanesthetized for withdrawal of the suture and reperfusion after 
90 min of MCAO. 
50% of all stroke cases are due to an occlusion of the middle cerebral artery. So far, it has 
been difficult to construct good models for human stroke. This could be due to the complexity 
and size of the human brain or, maybe even more importantly, that humans and rodents differ 
in regard to the vascularization and composition of the brain parenchyma. Further, in humans 
white matter constitutes ~40% of the brain, compared to ~10% in rodents. Stroke in humans 
predominantly involve white matter, whereas rodent models primarily assess grey matter 
damage. Thus, this represents an intrinsic bias in all currently available rodent models. This 
notwithstanding, MCAO has proved valuable as a model for recanalized stroke in humans. 
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Mouse model for acute hyponatemia  
In paper III we utilized a mouse model for acute induction of hypotonic hyponatremia “water 
intoxication”. In this model the mice receive a 10% of body weight bolus of ion free water 
with a vasopressin receptor II antagonist (0.4 g/kg) intraperitoneal. The dilutional effect of 
the added water will inevitably yield hyponatremia. The pro of this model is that it is fast and 
easily reproducible model, with no major confounding factors. However, the 
pathophysiological relevance to hyponatremia in human may be debated. In man, 
hyponatremia is often caused by an underlying, pathogenic process.  
This notwithstanding, severe hyponatremia may already develop during a 2 ½ h Marathon 
race in healthy athletes (Almond et al., 2005). Excess intake of fluids, extensive sweating and 
reduced kidney function (sympaticus activity during the race and painkillers (NSAIDs)) all 
contribute in lower serum sodium. Thus, the slope of the drop of serum sodium may be 
similar to the acute mouse model, but this is currently unknown as blood samples are only 
taken after the race. In effect, we believe that the model is a valid model for acute hypotonic, 
dilutional hyponatremia.  
Models for experimental meningitis 
Backdrop 
The recent development of murine models for bacterial meningitis offers tools for exploring 
the host-pathogen interaction in vivo (Chiavolini et al., 2008).  
Two major types of murine meningitis models exist: 1) direct infection by the intracerebral or 
the intracisternal  route or 2) infection induced by the intraperitoneal or intranasal route. 
Direct bacterial inoculation into the CNS mimics the contiguous spread of bacteria from the 
nasopharynx or traumatic inoculation into the brain.  
Thus, this allows the study of host-pathogen interactions once infection is established in the 
meninges, but does not enable the analysis of the different pathogenic steps occurring from 
colonization to disease in the CNS. In contrast, meningitis induced via intranasal or 
intraperitoneal routes is useful for the analysis of the pathogenesis according to the natural 
way of infection, but the model is hampered by the fact that many mice die of disseminated 
sepsis without ever developing meningitis. 
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As S. pneumonia is a naturally virulent pathogen in mice, the current models are only 
validated with pneumococcal meningitis (Chiavolini et al., 2004; Orihuela et al., 2009).  
Alas, since N. meningitidis is a human-specific pathogen there have thus far not been any 
good animal models for meningococcal meningitis available (Johansson et al., 2005; 
Zarantonelli et al., 2007).  
 In order to benefit from the ever increasing number of transgenic mice strains it is paramount 
to establish a valid mouse model for meningococcal meningitis.  
Method 
We utilized the direct inoculation approach, with modified protocol from Chiavolini et al., 
2004. Meningitis was introduced in mice by intracranial (i.c.) injection of live meningococci. 
Mice were anesthetized with a subcutaneous injection (s.c.) of fentanyl/fluanison and 
benzodiazepine (Hypnorm/Dormicum) and the head was secured in a stereotactic frame. The 
skin on top of the head was incised and the bregma was then localized, and a burr hole was 
made 0 mm lateral and 3.5 mm rostral to the bregma. A blunted 30-gauge needle attached to a 
gas-tight glass syringe was stereotactically introduced through the burr hole, 2 mm ventral. 
After 1 min, the challenge dose was infused using an injection pump set at 5 µl/min, and 30 
sec after complete injection, the needle was gradually removed. In control studies only saline 
and Fe was infused. The whole in the scalp and the skin opening on top of the head were 
closed using bonewax and topical tissue adhesive, respectively. Intra peritoneal (i.p.) 
injections of Fe were given to selected mice to enhance the Mc infection. Pain relief 
(Temgesic) or eye protection was administered.  Mice were either wrapped in paper to keep 
warm (i.e. no specific temperature control) or the body temperature was regulated using a 
heating lamp. Temperature controlled animals received subcutaneous injections of 0,5 ml 
0,85% saline at 0, 5 and  20 h post injection and rectal temperature was monitored at the same 
intervals.  
The mice were humanly sacrificed by decapitation or cardiac puncture at different time 
intervals post infection. In cases of severe symptoms, the mice were humanly sacrificed 
immediately. After sacrifice, CSF and blood samples were collected and inoculated on 5% 
human blood agar. Mice brains were surgically removed and processed for further analyses.  
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8.3 Future perspectives 
The present thesis work has addressed central issues in brain pathophysiology. A number of 
questions will have to be addressed in future studies: What is the physiological importance of 
OAPs formation, and how is single channel AQP4 water permeability regulated?  
Does AQP4 modulate the function of other molecules (e.g. ion channels), facilitate the  
movement of solutes or contribute in osmosensing? 
What are the direction and magnitude of water transport through AQP4 in different membrane 
domains in physiology and during pathogenesis? 
 I shall limit myself to elaborate on the more concrete approaches that could be derived from 
this thesis.  
Our finding in paper I warrant further studies aiming at unraveling the mechanism for the 
proposed -syntrophin independent pool of AQP4 in the retina, where other syntrophin 
members (e.g. 1-syntrophin) are prime candidates as well as members of the utrophin 
complex.  It is also important to resolve the molecular basis for anchoring of AQP4 in the 
subpial membrane and other dystrophin independent domains in the brain and the 
mechanisms for local regulation of AQP4 in the brain. Further, it is of utmost importance to 
unravel the hitherto unknown protein that is responsible for the anchoring of AQP4 in concert 
with Dp71 and -syntrophin in the brain and retina.   
Our main finding in paper II that AQP4 undergoes a dramatic downregulation in the 
infarction core warrants further insight into the potential mechanisms involved. In ischemia 
and reperfusion the cells undergo dramatic metabolic and molecular changes and thus a 
plethora of mechanism could be involved. However, one prime candidate is the MMPs that 
have been shown to be consistently involved in blood-brain barrier distruption, subsequently 
leading to vasogenic edema. The DAPC is attached through dystroglycans to laminin and 
agrin, both substrates for MMPs. Therefore, in vitro single molecular tracking of AQP4 after 
activation of MMPs could elucidate the impact of proteolysis on AQP4 expression.  
AVP is often non-specifically released in acute intracranial pathology.   
There is substantial evidence that activation of the V1-receptor and PKC, may phosporylate 
and downregulate AQP4. A phosphorylation assay after MCAO could elucidate if AQP4 is 
massively phosphorylated in stroke.   
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In paper III, our finding that AQP4 undergoes dynamic changes in the subpial and other 
membranes after hyponatremia, whereas the total protein expression is unchanged in 
immunoblot analysis, begs the question if the OAPs structure and immunoreactivity is 
changed. One feasible approach is to assess the OAPs with freeze fracture. Further, to unravel 
the phosphorylation dynamics a phosphorylation assay is of paramount importance. A 
possible experiment to elucidate the importance of the subpial pool in the clearance of water 
during hyponatremia by bulk flow into the SAS would be to administer AQP4 inhibitors into 
the CSF that could selectively block the pool of APQ4 in the subpial membrane.  
As the predominant type (if any in particular) of edema in meningitis is still not clear-cut
a DWI MRI is a natural step forward to gain understanding of the edema mechanisms in our 
new mouse model for meningococcal meningitis, as the diffusion is increased in vasogenic 
and hydrocephalic edema, but decreased in cytotoxic brain swelling.  
AQP4 as a therapeutic target 
AQP4 is undoubtedly a promising target for therapeutic intervention both in stroke, 
hyponatremia and meningitis as discussed in this thesis.  
Thus far, we do not have an adequate molecular understanding of how we should target 
AQP4. We need more basic understanding of AQP4 in normal brain physiology before we 
can consider manipulating AQP4.  
We must not forget that the complexity of the human blood-brain barrier impedes the access 
of drug candidates to their intracerebral targets. Nevertheless, the current construction of 
small molecular ligands will be an important step in validating the therapeutic potential of 
AQP4 inhibition. One possible approach is to construct peptides with high affinity to PDZ 
domains that could compete with the binding between the terminal SSV sequence of AQP4 
and its anchoring molecule, -syntrophin.  
Peptide ligands are likely to be inefficient as the BBB has low permeability to peptides. But, 
peptides could be conjugated to more lipophilic substances or could be used as 3D models for 
the generation of non-peptide ligands. The timing for application of potential AQP4 inhibitors 
is of utmost importance, given the specific time course of changes observed after MCAO 
(present study). Clearly, more work needs to be done in order to provide a platform for a 
novel therapy for brain edema.  
53
The polarization of AQP4 in the perivascular endfeet is contingent on OAPs. 
Hitherto, the exact role of OAPs formation in controlling single channel water transport is 
unresolved.  Palmitoylation has been shown to regulate the size, an maybe the water transport, 
through OAPs. Thus, AQP4 could potentially be targeted by manipulating the formation of 
OAPs.  
A future therapy based on AQP4 inhibition can be expected to offer only partial protection 
against edema formation. Water may diffuse through the narrow slits that separate the endfeet 
and might also be transported along with other molecules. It should also be recalled that water 
is able to diffuse (albeit at a very low rate) through the lipid bilayer of the plasma membrane. 
Besides, in the vasogenic phase of a postischemic edema, the blood-brain barrier breaks 
down, leading to extravasation of albumin and other plasma proteins. Hence, osmotic forces 
and the loss of blood-brain barrier integrity will lead to influx of water independently of 
AQP4. But AQP4 could be of benefit by stimulating bulk flow of water and osmolytes out of 
the brain as to counteract the edema formation. 
It should be emphasized that there are several other potential therapeutic targets in early brain 
edema formation. Proposed key players are cotransporters such as NKCC1, where the loop 
diuretic bumetanide is a promising candidate. In fact, there is recent evidence that bumetanide 
may inhibit AQP4 water permeability in Xenopus oocytes and downregulate perivascular 
AQP4 during transient ischemia (Migliati et al., 2009; Migliati et al., 2010). If so, the use of a 
previously approved drug may by pass many hurdles for AQP4 as a target in protection 
against brain edema. An approach directing both cotransporters and AQP4 are likely to be 
efficient in reducing edema formation. 
Further, glutamate excitotoxicity, caused by excessive glutamate release during an ischemic 
event, is a major contributing factor to neuronal perturbation and subsequent apoptosis. In 
stroke, glutamate excitotoxicity and edema formation mutually aggravate each other.  Future 
therapy should target both glutamate excitotoxicity and edema formation to interrupt this 
vicious circle. Such a combined approach, targeting several molecular pathways, would 
hopefully have an additive effect on reducing the edema formation and improve the prognosis 
of cerebral brain edema.    
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9. CONCLUDING REMARKS 
Brain edema is still in the 21st century a feared complication in a plethora of intracranial and 
systemic disorders. AQP4 is a promising target for therapeutic intervention targeting brain 
edema. However, AQP4 has shown to be a Janus-faced player in brain edema formation as 
AQP4 has a deleterious effect in mouse models with cytotoxic and osmotic brain edema, 
whereas AQP4 has a protective role in models of vasogenic and hydrocephalic edema.  
This thesis has further explored the expression and polarization of AQP4 in relevant 
pathologies. Thus, it is of paramount importance to know the spatiotemporal changes of 
AQP4 expression in the disease process. The main conclusion is that AQP4 undergoes 
dynamic changes both in polarization and distribution. This new knowledge should be 
emphasized in the consideration of AQP4 as a therapeutic target 
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The aquaporin-4 (AQP4) pool in the perivascular astrocyte mem-
branes has been shown to be critically involved in the formation
and dissolution of brain edema. Cerebral edema is a major cause of
morbidity and mortality in stroke. It is therefore essential to know
whether the perivascular pool of AQP4 is up- or down-regulated
after an ischemic insult, because such changes would determine
the time course of edema formation. Here we demonstrate by
quantitative immunogold cytochemistry that the ischemic striatum
and neocortex show distinct patterns of AQP4 expression in the
reperfusion phase after 90 min of middle cerebral artery occlusion.
The striatal core displays a loss of perivascular AQP4 at 24 hr of
reperfusion with no sign of subsequent recovery. The most af-
fected part of the cortex also exhibits loss of perivascular AQP4.
This loss is of magnitude similar to that of the striatal core, but it
shows a partial recovery toward 72 hr of reperfusion. By freeze
fracture we show that the loss of perivascular AQP4 is associated
with the disappearance of the square lattices of particles that
normally are distinct features of the perivascular astrocyte mem-
brane. The cortical border zone differs from the central part of the
ischemic lesion by showing no loss of perivascular AQP4 at 24 hr of
reperfusion but rather a slight increase. These data indicate that
the size of the AQP4 pool that controls the exchange of ﬂuid
between brain and blood during edema formation and dissolution
is subject to large and region-speciﬁc changes in the reperfusion
phase.
astrocytes  brain edema  ischemia  stroke  water channels
S troke is invariably associated with a brain edema that ac-counts for much of the morbidity and mortality of this
condition. The brain edema is often long lasting and therapy-
resistant and thus poses a major challenge in the clinic. A better
understanding is needed of the molecular mechanisms that
promote water flux across the brain–blood interface in the
build-up phase and resolution phase of cerebral edema.
Aquaporin-4 (AQP4) water channels are strongly enriched in
the astrocyte plasma membrane domains that ensheathe the
cerebral microvessels (1, 2). It was hypothesized (1) that this
perivascular pool of AQP4 could become rate-limiting for water
flux in pathophysiological conditions, such as in the reperfusion
phase after an ischemic insult. This hypothesis was tested in a
model that took advantage of the fact that the perivascular AQP4
pool is anchored through the dystrophin complex (comprising
the brain dystrophin isoform DP-71 and -syntrophin) (3). Mice
with targeted deletion of -syntrophin displayed a dramatic loss
of perivascular AQP4 and a concomitant reduction in the extent
of postischemic edema (4). These findings [and experiments in
mdx mice (5)] support the idea that the perivascular pool of
AQP4 facilitates water flux across the brain–blood interface and
offer a mechanistic explanation for the reduction in brain edema
formation and dissolution observed in AQP4/ animals (6, 7)
The implication of a specialized class of membrane molecule in
the pathophysiology of brain edema instills hope for new therapy
that could complement the current treatment strategies based on
surgical decompression or infusion of hyperosmolar solutions.
A critical question is whether the perivascular pool of AQP4
is down- or up-regulated during or after a transient ischemic
insult. If astrocytes respond to ischemia by down-sizing the
perivascular pool of AQP4, this would delimit water uptake but
would also reduce the potential for any therapeutic intervention
targeting AQP4.
The aim of this work was to unravel the time course of AQP4
expression at the blood–brain interface, after transient ischemia
induced by middle cerebral artery occlusion (MCAO). The
postembedding immunogold procedure is uniquely suited to this
task, because it offers a semiquantitative assessment of the
AQP4 pool in distinct membrane domains (8). Immunoblot
analyses are not relevant, because the total amount of AQP4 in
the neuropil is poorly correlated with the size of the perivascular
pool of this protein. Indeed, disruption of the anchoring of the
endfoot pool of AQP4 led to a mislocalization, rather than a net
loss of AQP4 (3).
Results
On the unaffected side (see Materials and Methods), double
immunofluorescence analysis showed colocalization of AQP4
with dystrophin (Fig. 1A) and -syntrophin (Fig. 1C) around
brain microvessels. The same staining pattern was found in the
border zone of the ischemic lesion and in ipsilateral cortical areas
more distant from the lesion. In the central part of the ischemic
neocortex, examined after 24 hr of reperfusion, the perivascular
pools of dystrophin (Fig. 1B) and -syntrophin (Fig. 1D) largely
persisted, whereas the perivascular pool of AQP4 was lost. Only
in deep regions of the cortex (and in the striatal core) were
vessels found that lacked immunoreactivity for AQP4 as well as
dystrophin and -syntrophin.
Prompted by the results of the immunofluorescence analysis,
we used a postembedding immunogold procedure to assess
AQP4 expression in the perivascular astrocyte membrane (Figs.
2 and 3). The loss of perivascular AQP4 immunoreactivity in the
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neocortical lesion at 24 hr of reperfusion was confirmed (Fig.
2F). Visual examination of earlier and later time points (includ-
ing 0 hr, Fig. 2C) revealed no or more modest losses, suggesting
that the perivascular AQP4 labeling reached minimum values at
24 hr.
The qualitative data were supplemented by a quantitative
immunogold analysis of the striatal and neocortical zones of the
ischemic lesion (Fig. 3). The contralateral side was used as an
internal reference in each animal to minimize the confounding
effect of possible differences in fixation efficiency. Each of the
four animals analyzed at 24 hr of reperfusion showed a statis-
tically significant loss of perivascular AQP4 in the central part of
the ischemic cortex, compared with the corresponding part of
the contralateral cortex (Fig. 3). On average, the labeling
decreased by 78%, with a minimum of 59% and a maximum of
93%. In contrast, none of the animals displayed any significant
loss of AQP4 from perivascular membranes of the cortical
border zone. This was true for each group of animals, irrespec-
tive of reperfusion time. Indeed, the labeling in the border zone
(the intensity of which was slightly depressed at the start of
reperfusion) tended to increase toward 24 hr and thence to
decrease toward control level (Fig. 3).
Supporting the qualitative analysis, the quantitative data
suggested that the pronounced loss of perivascular AQP4 in
the central part of the ischemic cortex at 24 hr was not a
precipitous event but rather a trough preceded by a gradual
decline and followed by a gradual restoration. Thus, at 24, 48,
and 72 hr of reperfusion, the loss of AQP4 averaged 78%, 58%,
and 45% with significance levels between 0.0058 and 0.0477.
At 2 and 6 hr of reperfusion, the immunogold density values
for AQP4 were 59% and 80% of control values, respectively,
and were not significantly different from these values (P values
of 0.07 and 0.36, respectively).
The data described above were obtained from the neocortex.
We also investigated AQP4 expression in the striatum, which
constitutes a major part of the ischemic core. The pattern of
changes in the striatum mimicked the pattern of changes in the
overlying neocortex, with one notable exception: The tendency
Fig. 1. Immunoﬂuorescence analysis of brains subjected to MCAO (neocor-
tex; 24 hr of reperfusion). (A and C) Contralateral neocortex, area opposite to
ischemic core. (B and D) Central part of ischemic cortex (Fig. 5, region 4).
Yellow labeling surrounding vessels in contralateral cortex indicates colocal-
ization (arrows) of AQP4 (green) and dystrophin (red in A) and -syntrophin
(red in C). In contrast, vessels in the ischemic cortex are associated with a red
signal (open arrowheads), indicating the absence of AQP4 and retention of
dystrophin (B) and -syntrophin (D). Filled arrowheads indicate the subpial
endfeet. Dys, dystrophin; -syn, -syntrophin. (Scale bar: 20 m.)
Fig. 2. Immunogold analysis of AQP4 expression immediately (0 hr in A–C)
and 24 hr (D–F) after the onset of reperfusion (0 hr). At 24 hr, there is a
pronounced reduction in the number of gold particles (arrows) over perivas-
cular membranes in central part of the ischemic cortex (F) compared with the
border zone (E) and contralateral side (D). In the ischemic cortex, AQP4
labeling remains over the abluminal membrane of the perivascular endfeet
(open arrows in F). E, endothelial cells; L, vessel lumen; P, pericyte. (Scale bar:
0.5 m.)
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toward a recovery of immunolabeling at 72 hr, obvious in the
neocortex, was not observed in the striatum (Fig. 3).
In the central part of the ischemic cortex, the abluminal
membrane of the endfeet showed scattered gold particles (Fig.
2F). This membrane domain is normally almost devoid of gold
particles signaling AQP4. The quantitative immunogold analysis
of the ischemic cortex revealed no alteration in the -syntrophin
expression level at 0 or 24 hr of reperfusion (data not shown).
Astrocyte endfeet were examined by freeze fracture (Fig. 4A).
At high magnification, AQP4 square arrays were abundant in the
endfoot membrane facing the capillary (Fig. 4B), and glial
fibrillary acidic protein (GFAP) filaments were abundant in the
cytoplasm (faintly detectable at the low magnification in Fig.
4A), with either marker providing for positive identification of
astrocyte processes. In the border zone (Fig. 4 C and D), AQP4
square arrays were abundant in membrane P-faces abutting
capillaries (Fig. 4C), and their imprints were abundant in endfoot
membrane E-faces (Fig. 4D). The P-faces correspond to the
replicated protoplasmic leaflet of split membranes, and the
E-faces represent replicated extraplasmic membrane leaflets (9).
Endfoot-like processes in the striatal core and overlying neo-
cortex lacked AQP4 square arrays in their plasma membranes
(Fig. 4F).
Discussion
The present work reveals that the expression level of the
perivascular pool of AQP4 undergoes major changes after a
transient ischemic insult. These results bear directly on the
molecular mechanisms underlying the generation and dissolu-
tion of postischemic edema, because the perivascular pool of
AQP4 allows bidirectional water flow and hence is likely to be
rate-limiting for both water influx and efflux (4).
Our data suggest a biphasic change in perivascular AQP4
expression in the most affected part of the ipsilateral cortex. The
initial reduction in AQP4 expression (with minimum values at
24 hr) will serve to delimit water influx, whereas the partial
recovery of the AQP4 level (from 24 to 72 hr; i.e., subsequent to
the culmination of the edema) would be expected to favor
absorption of excess fluid. This pattern of changes contrasts with
the changes that occur in the cortical border zone. Here, a trend
toward an elevated level of AQP4 expression was observed at a
Fig. 3. Time course of AQP4 expression after MCAO. Values along the
ordinate represent linear density of gold particles over perivascular mem-
branes (same samples as in Fig. 2). Density values were obtained from the
central part of the ischemic cortex (blue), striatal part of the core (green), and
cortical border zone (red). The horizontal black line indicates the reference
level (calculated from the neocortex and striatum contralateral to the lesion).
The values for the ischemic cortex (blue) and striatal core (green) are signiﬁ-
cantly different from the reference values for reperfusion times of 24, 48, and
72 hr. The corresponding P values are 0.0058, 0.0122, and 0.0477 (cortex) and
0.0043, 0.0076, and 0.0052 (striatum), respectively.
Fig. 4. Conventional freeze fracture images from
contralateral cortex (A and B), cortical border zone (C
and D), and central part of ischemic lesion (E and F), all
from 24 hr of reperfusion after MCAO. (A) Low-
magniﬁcation image from contact region between
astrocyte endfoot (white asterisk) and the edge of
capillary (black asterisk in cytoplasm). Boxed area en-
closes P-face of astrocyte, shown at higher magniﬁca-
tion in B. Nu, endothelial nucleus. (B) High-magniﬁca-
tion view of P-face of astrocyte endfoot plasma
membrane, showing 100 AQP4 arrays in 0.3 m2.
(C) P-face of astrocyte endfoot in border zone has
AQP4 arrays at approximately the same density as in
contralateral control. (D) E-face view of AQP4 im-
prints, also from border zone. (E) Low-magniﬁcation
view of capillary in central part of ischemic lesion.
Membrane debris is present in the lumen of the cap-
illary. Boxed area including presumptive astrocyte
endfoot shown at highermagniﬁcation in F. The black
asterisk indicates endothelial cytoplasm. (F) High-
magniﬁcation image of E-face of presumptive astro-
cyte endfoot in central part of ischemic lesion. AQP4
arrays were not detected in this or any other mem-
brane adjacent to capillaries. The black asterisk indi-
cates endothelial cytoplasm.B–D and F are at the same
magniﬁcation. (Calibration bars: A and E, 1 m; B, C,
and F, 0.1 m.)
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time when the AQP4 expression was decreased in the central
part of the ischemic cortex.
The present data clearly show that the cortical region most
severely affected by the ischemic insult behaves differently from the
striatal core when it comes to changes in AQP4 expression in the
postischemic phase. Notably, unlike the striatal core, the ischemic
cortex shows a partial recovery of perivascular AQP4 toward 72 hr
of reperfusion. Taken together with our finding of persistent
-syntrophin and dystrophin labeling, the latter observation sug-
gests that the affected cortex (with the possible exception of the
deepest layers) differs from the striatal core by preserving, for 72
hr at least, the integrity of astrocyte membranes after the MCAO
insult. On this background we have chosen to distinguish the
affected cortex from the striatal core by using the term ‘‘central part
of the ischemic cortex’’ rather than the term ‘‘cortical core.’’
The persistence in the cortex of dystrophin and -syntrophin in
the perivascular membrane leaves us with a mechanistic model in
which ischemia disrupts the coupling between AQP4 and its
anchoring complex. Rapid changes in the size of the perivascular
AQP4 pool can be envisaged if the anchoring is severed, because of
the high AQP4 concentration gradient between perivascular mem-
branes and other membrane domains (including the abluminal
endfoot membrane, which showed increased labeling after isch-
emia). Our findings are consistent with the idea that an ischemia-
induced perturbation ofAQP4 anchoring permits a lateral diffusion
of AQP4, thereby draining the pool of AQP4 that normally resides
in the perivascular membrane. This explanation is in line with
previous observations in transfected HEK 293 cells, indicating that
truncated AQP4 (lacking the three C-terminal residues that are
essential for binding to the dystrophin complex) disappears much
more quickly from the membranes than WT AQP4 (3).
Theoretically, the loss of AQP4 immunosignal could be due to
conformational changes in AQP4 with a subsequent loss of
affinity for the selective antibodies. This possibility could be
ruled out by the freeze fracture analysis, which demonstrated a
complete loss of the square lattices of particles from the endfoot
membranes. Expression studies and analysis of AQP4-null ani-
mals have provided conclusive evidence that these square lattices
correspond to arrays of AQP4 (10, 11).
We have previously shown by Western blotting that disruption
of AQP4 anchoring at the perivascular membrane leads to a
mislocalization of AQP4 rather than a net loss (3, 8). Previous
studies of the effects of ischemia on AQP4 have not focused on
the perivascular (rate-limiting) pool of AQP4 but have analyzed
the tissue contents of AQP4 or the level of AQP4 mRNA
(12–14). There is evidence of an increased synthesis of AQP4 in
the periinfarct zone after MCAO or stroke (14).
The persistence of the perivascular AQP4 pool in the cortical
border zone suggests that partial ischemia is not sufficient to
interfere significantly with anchoring of AQP4 (although the
initial drop in AQP4 expression may be indicative of a transient
effect on the anchoring mechanisms). This finding could be
exploited diagnostically in attempts to assess the relative volumes
of the central part and border zone of the ischemic lesion, given
the availability of a ligand that binds selectively to the perivas-
cular pool of AQP4. Our findings are in agreement with a recent
study (15) which shows that osmotherapy with 7.5% hyperos-
motic saline at 24 hr after MCAO in rats leads to a significant
decrease in the brain water content in the cortical border zone
(where the perivascular AQP4 expression is retained) but not in
the central part of the lesion (where the perivascular AQP4
expression is strongly reduced).
In conclusion, our data suggest that the size of the AQP4 pool
that controls the exchange of fluid between brain and blood
during edema formation and dissolution is subject to large
changes during the reperfusion phase. The magnitude and
direction of these changes serve to distinguish the central part
from the border zone of the ischemic lesion and must be taken
into account in future strategies to develop new therapies
targeting AQP4 or associated molecules in the perivascular
membrane.
Materials and Methods
Animals. Experimental protocols were approved by the Institu-
tional Animal Care and Use Committee and conform to Na-
tional Institute of Health guidelines for the care and use of
animals. Studies were conducted with male WT C57BL mice
allowed ad libitum access to food and drinking water.
Brain Ischemia. Twenty-one mice with body weights of 27–32 g were
anesthetized with 1–1.2% halothane in oxygen-enriched air, and
rectal temperature was maintained at 37 
 0.5°C with heating
lamps during the entire surgical procedure. Mice were then sub-
jected to MCAO in a randomized fashion as described previously
(4).MCAOwas verified at 30min by allowing the animal to awaken
and performing neurological deficit scoring as follows: 0, normal
motor function; 1, flexion of torso and of contralateral forelimb
upon lifting by the tail; 2, circling to the contralateral side but
normal posture at rest; 3, leaning to the contralateral side at rest;
4, no spontaneous motor activity. Mice with clear neurological
deficits (score of 2) were reanesthetized for withdrawal of the
suture and reperfusion after 90 min of MCAO. The mice were
perfused for immunocytochemistry at different time points after
the onset of reperfusion (0, 2, 6, 12, 24, 48, and 72 hr). A few animals
were excluded because of subarachnoidal hemorrhage. The final
numbers of animals included for electronmicroscopic analysis were
three for 0, 2, 6, 12, and 48 hr of reperfusion; four for 24 hr of
reperfusion; and two for 72 hr of reperfusion. Two additional
animals were perfused at 24 hr for immunofluorescence analysis.
The use of the contralateral side as reference gave statistical
significance with a relatively low number of animals (see below).
Tissue was sampled from the striatal core and the overlying
neocortex (the ‘‘central part of the ischemic cortex’’). Samples
were also collected from the neocortical border zone (defined as
the most peripheral zone of the affected cortex and with less
distinct pallor than the core).
Antibodies. Antibodies to AQP4 (polyclonal, Alpha Diagnostics,
San Antonio, TX; monoclonal, Serotec, Oxford, U.K.), -syn-
trophin [polyclonal (16)], or dystrophin (polyclonal, raised
against the C terminus of DP-71; Abcam, Cambridge, U.K.) were
used in the present work. The properties of the antibodies have
been described (3, 17, 18). The selectivity of the labeling was
confirmed by omission of the primary antibody or preadsorption
with the immunizing peptide.
Electron Microscopy. Mice were perfused through the heart with 4%
formaldehyde in phosphate buffer at pH 6.0, then pH 10.0 (4). For
quantitative immunogold studies, tissue blocks were dissected from
a 1.0-mm-thick coronal slice through the forebrain. The tissue
blocks did not exceed 1 mm in any dimension and were dissected
from each of the following five regions (Fig. 5): 1, contralateral
neocortex; 2, contralateral striatum; 3, cortical border zone; 4,
central part of the ischemic cortex; and 5, striatal core. The tissue
blocks were cryoprotected, quick-frozen in liquid propane
(170°C), and subjected to freeze substitution (3, 19). Specimens
were embedded in methacrylate resin (Lowicryl HM20; Poly-
sciences, Warrington, PA) and polymerized by UV light below 0°C.
Ultrathin sections were incubated with antibodies to AQP4 (poly-
clonal, 10 gml) or -syntrophin (1:100) followed by goat anti-
rabbit antibody coupled to 15-nm colloidal gold. The sections were
examined in a Philips (Eindhoven, The Netherlands) CM10 elec-
tron microscope at 60 kV (20, 21).
Fluorescence Microscopy. For immunof luorescence we used
16-mcryostat sections obtained from brains that had been fixed
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as described above. The sections were incubated with an anti-
body to AQP4 (monoclonal, 10 gml) together with anti-
dystrophin (5 gml) or anti-syntrophin (1:500) followed by
Alexa Fluor 448-conjugated donkey anti-mouse and Cy3-
conjugated goat anti-rabbit IgG antibodies and were then viewed
and photographed with a Zeiss (Oberkochen, Germany) LSM 5
Pascal confocal microscope (8).
Freeze Fracture. Formaldehyde-fixed tissue blocks from the core
region, the border zone, and the contralateral cortex were sectioned
at 150 m, infiltrated with 30% glycerol, frozen by contact with a
liquid nitrogen-cooled metal mirror (ULTRA-FREEZE MF7000;
RMC Products, Tucson, AZ), fractured and replicated in an
RMCJEOL (JEOL, Tokyo, Japan) 9010c freeze fracturemachine,
and cleaned with 5.25% sodium hypochlorite bleach (22). Replicas
were examined at 100 kV in a JEOL (Peabody, MA) 2000 EX-II
transmission electron microscope (TEM). Astrocyte endfeet adja-
cent to capillaries were photographed stereoscopically at magnifi-
cations of10,000–50,000, with 8° included angle between images.
TEM negatives were scanned and digitized by using an ArtixScan
2500f digital scanner (Microtek, Carson, CA) and processed with
Adobe Photoshop CS by using minimal (or no) ‘‘unsharp mask,’’
maximal contrast expansion with ‘‘levels,’’ and selected area ‘‘dodg-
ing’’ using brightnesscontrast functions to optimize image contrast
and definition.
Quantification and Statistical Analysis. For the quantification of
AQP4 immunogold labeling, 15–20 digital (16-bit) images from
each section (one section per block, giving a total of 1,426 images)
were acquired in a blinded manner and quantified with a commer-
cially available image analysis program (analySIS; Soft Imaging
Systems, Mu¨nster, Germany) (8, 17). Perivascular labeling was
measured as gold particles per unit length of astrocyte membrane
in direct contact with the pericapillary basal lamina (linear particle
density). Particles were included if their centers were localized
within 30 nm of the midpoint of the membrane (23). Linear
densities of gold particles over astrocyte membranes were deter-
mined by an extension of analySIS (Soft Imaging Systems) as
described (8, 24). Curves were drawn interactively, and linear
densities were determined semiautomatically and transferred to
SPSS Version 13 (SPSS, Chicago, IL). Values for individual curve
segments were averaged per section (block, animal).
Data were analyzed by a linear mixed model, using the lme
function in R (25). Fixed effects were first included for every
combination of region and reperfusion time. We assumed a de-
pendency structure with random effects on animals and on regions
inside animals. Parameter estimates were obtained by maximum
likelihood for the fixed effects and by restricted maximum likeli-
hood for the variances of the randomeffects. It was found that there
were no significant difference in gold particle densities over times
for the control regions (contralateral neocortex and striatum; P
value of 0.434). Hence, we chose to represent these two regions by
a single fixed effect. We assumed a model with variances that differ
between regions. For a detailed description see www.med.uio.no
imbstatimmunogoldindex.html.
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Fig. 5. Diagram of coronal slice through the forebrain. The shaded area on
the right side is the area affected by ischemia. Specimens were dissected from
the following: 1, contralateral neocortex (control); 2, contralateral striatum
(control); 3, cortical border zone; 4, central part of ischemic cortex; and 5,
striatal part of the ischemic core.
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